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Abstract
In drug discovery, thousands of compounds are assayed to detect activity against a
biological target. The goal of drug discovery is to identify compounds that are active
against the target (e.g. inhibit a virus). Statistical learning in drug discovery seeks
to build a model that uses descriptors characterizing molecular structure to predict
biological activity. However, the characteristics of drug discovery data can make
it difficult to model the relationship between molecular descriptors and biological
activity. Among these characteristics are the rarity of active compounds, the large
volume of compounds tested by high-throughput screening, and the complexity of
molecular structure and its relationship to activity.
This thesis focuses on the design of statistical learning algorithms/models and
their applications to drug discovery. The two main parts of the thesis are: an
algorithm-based statistical method and a more formal model-based approach. Both
approaches can facilitate and accelerate the process of developing new drugs. A
unifying theme is the use of unsupervised methods as components of supervised
learning algorithms/models.
In the first part of the thesis, we explore a sequential screening approach, Cluster
Structure-Activity Relationship Analysis (CSARA). Sequential screening integrates
High Throughput Screening with mathematical modeling to sequentially select the
best compounds. CSARA is a cluster-based and algorithm driven method. To
gain further insight into this method, we use three carefully designed experiments
to compare predictive accuracy with Recursive Partitioning, a popular structure-
activity relationship analysis method. The experiments show that CSARA outper-
forms Recursive Partitioning. Comparisons include problems with many descriptor
sets and situations in which many descriptors are not important for activity.
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In the second part of the thesis, we propose and develop constrained mixture
discriminant analysis (CMDA), a model-based method. The main idea of CMDA
is to model the distribution of the observations given the class label (e.g. active
or inactive class) as a constrained mixture distribution, and then use Bayes’ rule
to predict the probability of being active for each observation in the testing set.
Constraints are used to deal with the otherwise explosive growth of the number
of parameters with increasing dimensionality. CMDA is designed to solve several
challenges in modeling drug data sets, such as multiple mechanisms, the rare target
problem (i.e. imbalanced classes), and the identification of relevant subspaces of
descriptors (i.e. variable selection).
We focus on the CMDA1 model, in which univariate densities form the building
blocks of the mixture components. Due to the unboundedness of the CMDA1 log
likelihood function, it is easy for the EM algorithm to converge to degenerate solu-
tions. A special Multi-Step EM algorithm is therefore developed and explored via
several experimental comparisons. Using the multi-step EM algorithm, the CMDA1
model is compared to model-based clustering discriminant analysis (MclustDA).
The CMDA1 model is either superior to or competitive with the MclustDA model,
depending on which model generates the data. The CMDA1 model has better
performance than the MclustDA model when the data are high-dimensional and
unbalanced, an essential feature of the drug discovery problem!
An alternate approach to the problem of degeneracy is penalized estimation. By
introducing a group of simple penalty functions, we consider penalized maximum
likelihood estimation of the CMDA1 and CMDA2 models. This strategy improves
the convergence of the conventional EM algorithm, and helps avoid degenerate
solutions. Extending techniques from Chen et al. (2007), we prove that the PMLE’s
of the two-dimensional CMDA1 model can be asymptotically consistent.
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Chapter 1
Drug Discovery and Data Sets
1.1 Drug Research
Drug discovery is a multidisciplinary endeavor occurring at the interface of biology,
chemistry, computer science, statistics and informatics. Its history can be traced
back over one hundred years. Drug research began when chemistry had reached
a degree of maturity that allowed its principles and methods to be applied to
problems outside of chemistry, and also when pharmacology had become a well-
defined scientific discipline.
1.1.1 The Evolution of Drug Discovery
By the 1870’s, drug research was affected heavily by some of the essential founda-
tions of chemical theory, such as Avogadro’s atomic hypothesis, the periodic table
of elements, the theory of acids and bases, and especially August Kekule’s pioneer-
1
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ing theory on the structure of aromatic organic molecules. Analytical chemistry,
in particular the isolation and purification of the active ingredients of medicinal
plants, also demonstrated its value for medicine in the 19th century. Between 1871
and 1918, as a series of new institutions were created to support interdisciplinary
drug research and development, a new way of finding, characterizing, and develop-
ing medicines led to the formation of a new industry, i.e. drug discovery (Drews
2000).
During the first half of 20th century, drug research was shaped and enriched by
several new technologies, all of which left their imprint on drug discovery and on
therapy (Drews 2000). For instance, microbiology, biochemistry and pharmacology
helped shape the course of drug discovery and bring it to a level where new drugs are
no longer generated solely by the imagination of chemists but result from a dialogue
between biologists and chemists. Also the main effect of molecular biology for drug
discovery lies in the potential to understand disease processes at the molecular or
genetic level and to determine the optimal molecular targets for drug intervention.
1.1.2 High-throughput Screening
With the advent of genomic sciences, rapid DNA sequencing, combinatorial chem-
istry and cell-based assays, drug discovery has entered into a new period. In this
new period, the critical problem is an ever-increasing number of targets and com-
pounds. Pharmaceutical companies participating in drug discovery measure (assay)
the activity of various chemical compounds against a biological target (e.g. a dis-
ease). With recent scientific and technological advances, such as larger chemical
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libraries (chemical groupings of compounds) and robotic systems, assays of tens of
thousands of compounds can be performed in a single day. This process is known
as high-throughput screening (HTS).
In the HTS process, a number of compounds are screened against a given target
and the compounds showing the biggest positive effect (e.g. hindering the develop-
ment of diseases) are carried forward for more detailed analysis. Compounds with
a positive effect above a predetermined threshold will be called active compounds
or hits. With the prospect of many potential targets, the efficient design of bio-
chemical assays is increasingly important. Methods for choosing compounds are
an essential part of this design process. Also HTS creates new opportunities for
structure-activity relationship (SAR) analysis and increases the need for effective
statistical methods to identify trends and relationships in the data. Further, al-
though the cost of testing a single chemical compound against a biological target is
small, testing hundreds of thousands of compounds can become quite costly. Hence,
sequential screening has been developed to help reduce costs and create a more ef-
ficient strategy to determine SAR models. Sequential screening will be described
in the next section.
1.1.3 The Sequential Screening Paradigm
In today’s drug discovery, HTS is unable to screen all possible compounds as the
estimated number of possible drug molecules is roughly 1040 (Valler & Green 2000).
Hence sequential screening (Engels & Venkatarangan 2001) has been developed
to help reduce costs and make HTS more efficient. Sequential screening combines
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HTS and virtual screening (a screening model) in one integrated screening process.
Instead of testing an entire chemical library against a biological target, only a
fraction of the library, known as the initial sample set, is assayed. The purpose
of the initial sample set is not to find as many actives as possible, but simply
to collect data on a diverse set of compounds in the chemical space, so that a
computational analysis of these data can identify trends and help to select a further
set of compounds to be screened.
The sequential screening process is described in Figure 1.1. The flow of the
process is as follows: The experiment starts with the initial sample of compounds,
which is run through the HTS process. A quantitative structure-activity relation-
ship (QSAR) analysis of the data is performed to identify descriptors (variables
that quantify the structure of molecules) relevant to the biological activity. In this
step, a model capable of predicting activity using descriptor values is fit using the
data from the initial set screened. On the basis of the first QSAR, the whole data
inventory is virtually screened in order to get a more focused set of compounds
(i.e. the compounds predicted to be active) for a second round of HTS. Virtual
screening of compounds consists of using the fitted model to predict activity for the
untested compounds. Depending on the success of the HTS on the focused set, the
project budget, and the available resources, one or more iterations of the HTS →
QSAR → virtual screen cycle may be undertaken before the final QSAR analysis.
The QSAR analysis in the sequential screening process is a supervised learning
problem, which uses both descriptors and biological activity of compounds to learn
a predictive model. In Section 1.2, several descriptor sets will be introduced.
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Figure 1.1: The Sequential Screening Paradigm.
1.2 Chemical Descriptors and Data Sets Used in
the Thesis
Computational chemists have been able to qualify a compound’s structure with
many different sets of descriptors. Todeschini & Consonni (2000) list many of
the available descriptors in their Handbook of Molecular Descriptors. Calculating
descriptors is far less expensive than assaying the entire library of compounds, and
as long as a set of descriptors can be generated, even compounds that do not yet
exist or are not part of the company’s chemical library can be virtually screened. In
this section, we focus on introducing two drug discovery assays and five descriptor
sets used in the thesis.
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Assay Descriptor Variables
Name Measurement # Compounds Set # Source
Yeast binary 75,873 BCUT 6 GlaxoSmithKline
continuous 75,873 BCUT 6 GlaxoSmithKline
AIDS binary 29,812 BCUT 6 GlaxoSmithKline
binary 29,374 BCUT 64 Feng et al. (2003)
binary 29,374 Constitutional (CON) 46 Feng et al. (2003)
binary 29,374 Property (PROP) 212 Feng et al. (2003)
binary 29,374 Topological (TOP) 261 Feng et al. (2003)
Table 1.1: Data sets used in the thesis.
1.2.1 Data Sets
Two assays are used in the thesis with a variety of descriptor sets, as summarized
in Table 1.1.
The first assay is from the National Cancer Institute (NCI) Yeast Anticancer
Drug Screen (Simon, Dunstan, Lamb, Evans, Cronk & Irvine 2000), and will be
referred to here as the Yeast data. The Yeast assay measures inhibition of human
tumor cancer growth. For a tumor to develop, there must be a series of mutations,
which cause cells to multiply uncontrollably. Because of the high degree of func-
tional homology in biological activity between yeast and mammalian cells, many
mutations can be modeled in yeast. Simon et al. (2000) carried out a screen of
over 100,000 compounds from the repository at the NCI’s Developmental Thera-
peutics Program to identify compounds that can inhibit the growth of the mutated
cells. Hence, the Yeast assay data measure the percentage growth inhibition of the
assayed compounds. Among 100,000 compounds screened, 75,873 are used in the
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final analysis after three stages of screening. For most analyses we will convert
the percentage inhibition to a binary inactive/active response. Of the 75,873 com-
pounds, 6,834 are considered active, because they have growth inhibition of at least
70% (Simon et al. 2000); the proportion of active compounds is 8.2%. The Yeast
data can be downloaded from http://dtp.nci.nih.gov/yacds (accessed April 26,
2003).
The second assay, from the NCI Developmental Therapeutics Program, re-
lates to the HIV/AIDS virus and will be called the AIDS data. A description
of this assay is provided by Lam, Welch & Young (2002). The original AIDS data
(about 32, 000 compounds) can be downloaded from http://dtp.nci.nih.gov/
docs/aids/aids data.html (accessed April 26, 2003). Some observations with
poor structure representations that are usually considered as non-drug candidates
have been deleted from the original data (Lam et al. 2002), leaving us about 29, 812
compounds in the data. Feng, Lurati, Ouyang, Robinson, Wang, Yuan & Young
(2003) used a slightly different assay data set, which has 29, 374 compounds. In
the thesis, we use both of these assays. The biological activity is the amount of
protection a compound gives to human CEM (immunofluorescence and cryoim-
munoelectron microscopy) cells from HIV-1 infection. Two assay classifications,
“moderately active” and “confirmed active”, have been combined to form an “ac-
tive” class (Lam 2001). There are approximately 2% actives.
The data for both assays were generated by HTS. When converted to a binary
outcome, the Yeast data have a higher proportion of active compounds than found
in the AIDS data. In general, these compounds are representatives of those in
Drug Research and Data Sets 8
pharmaceutical data sets. Although they are not completely typical as they include
“toxic” compounds, which may selectively kill cancer cells, they should still provide
useful information on the effectiveness of the QSAR sampling/analysis strategies.
In all experiments, we will treat the available data as if they were a compound
library, and pretend to observe activity for selected subsets of the library. This will
enable us to simulate the sequential screening process summarized in Figure 1.1.
Various descriptor sets, as summarized in Table 1.1, will be used to character-
ize chemical structure in the QSAR modeling. The next section describes these
descriptor sets.
1.2.2 Chemical Descriptor Sets
Throughout the thesis, we shall assume that all descriptors are numeric variables,
rather than categorical. Below we list various descriptor sets used in subsequent
chapters.
6 BCUT descriptors
There are mainly three persons or research groups that have contributed to the
evolution of BCUT descriptors. Burden (1989) originally suggested construct-
ing a modified connectivity matrix to represent the hydrogen-suppressed con-
nection table of the molecule. To build this connectivity matrix, the atomic
numbers of the elements were put on the diagonal and values describing bond-
type of each pair of atoms are put on the off-diagonal. The aim of his work was
to produce descriptors that are highly compact but with minimal redundancy.
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Based on the assumption that the smallest eigenvalues contain contributions
from all the atoms and thus reflect topology of the molecule, the two smallest
eigenvalues of this matrix were used as chemical descriptors of the molecule.
The essence of the method is to solve the eigenvalue equation
BV = V e, (1.1)
where B is a real symmetric connectivity matrix to be defined. V is a matrix
of eigenvectors, and e is a diagonal matrix of eigenvalues. Elements of the
connectivity matrix are constructed so that the off-diagonal elements repre-
sent the strength of connection between atoms, and the diagonal elements the
size of the elements. The rules defining B used in Burden’s method are as
follows:
(a) Hydrogen atoms are not included.
(b) The rows and columns of the connectivity matrix are arbitrarily num-
bered according to the heavy atoms.
(c) The diagonal elements of B, Bii, are the atomic numbers of the atoms.
(d) The element of B connecting atoms i and j, Bij, is 0.1 for a single bond,
0.2 for a double bond, 0.3 for a triple bond, and 0.15 for an aromatic
delocalized bond.
(e) Elements of B corresponding to bonds to terminal atoms (i.e., atoms
with one connection only) are augmented by 0.01.
(f) All other elements of B are set at 0.001.
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Figure 1.2: Some fragment structures for formula C4H4.
According to the above rules, the different fragment structures with the same
formula can have different eigenvalues. For example, Figure 1.2 illustrates
several fragment structures for a formula C4H4. The first two lowest eigen-
values for these fragment structures are given in Table 1.2. It is clear that
even though these fragments have the same formula C4H4, but they have
different eigenvalues due to their different molecular structures. Figure 1.3
shows the scatter plot of these eigenvalue descriptors in Table 1.2 for C4H4. It
is interesting to see that (a) is close to (b); (d) is close to (e) and (f) is distant
from all other compounds. From the structures of these fragment, we notice
that (a) and (b), (d) and (e) are similar, while (f) is much more different from
others. Therefore, the similar structures have close BCUT descriptors.
Burden’s seemingly far-fetched ideas were successfully confirmed by Rusinko
and Kipkus (A. Rusinko and A. H. Kipkus, unpublished result obtained at
Chemical Abstract Service, Columbus OH) in 1993. They found structure
searches based on Burden’s suggestion were surprisingly comparable to the
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Table 1.2: Descriptors for some C4H4 fragments.
results of accepted similarity searching procedures. Pearlman & Smith (1999)
were inspired by the success of Rusinko and Kipkus, and extended Burden’s
approach of using one connectivity matrix to using multiple connectivity
matrices. They proposed constructing three classes of matrices: one class
with atomic charge-related values on the diagonal, a second class with atomic
polarizability-related values on the diagonal, and a third class with H-bond-
abilities on the diagonal. Also they put a variety of additional information on
the off-diagonal including functions of inter-atomic distance, overlaps, com-
puted bond-orders, etc. In addition to the smallest eigenvalue of each of the
three connectivity matrices (as Burden suggested) Pearlman & Smith (1999)
also used the largest eigenvalue of each matrix, which leave us in total 6 BCUT
descriptors. The advantage of six BCUT numbers over other descriptors is
their low dimensionality, which allows many statistical tools to be applied.
However, they are not easy to interpret in terms of chemical structure.
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Figure 1.3: Scatter plot of the formula C4H4 using the descriptors in Table 1.2.
64 BCUT descriptors
Feng et al. (2003) considered four connectivity matrices presenting atomic
properties — atomic mass, van der Waals volume, atomic electronegativity,
and atomic polarizability. Instead of using the largest and smallest eigenvalues
of each connectivity matrix, they used the eight largest and the eight smallest
eigenvalues of each atomic property matrix, which give in total 16× 4 = 64
BCUT descriptors.
46 Constitutional descriptors (CON)
The Constitutional descriptors are the measurements of the “constitution”
of a compound. The 46 descriptors include information such as molecular
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weight, atomic weight, atomic counts, etc. They depend only on the atoms
in a molecule but not specifically on the connections between the atoms. For
instance, the molecular weight of a compound is calculated as the sum of the
atomic weight of all the atoms that make up one molecule of the compound
without looking at their connectivity. Generally speaking, larger molecules
will have higher values for all of the Constitutional descriptors. Many different
molecules might have the same values of constitutional descriptors as there are
many ways that the same atoms can be connected to make a valid molecule.
212 Property/Fragment Descriptors (PROP)
Property descriptors reflect physicochemical properties of molecules, like log P
(the octanol-water partition coefficient, a measure of the hydrophobicity and
hydrophilicity of a substance. In the context of drug-like substances, hy-
drophobicity is related to absorption, bioavailability, hydrophobic drug-receptor
interactions, metabolism and toxicity), aromatic index, etc. They also include
fragment descriptors, which indicate the kinds of fragments in a molecule
and their frequencies. The fragments include atom/bond sequences and aug-
mented atoms.
261 Topological Index (TOP)
The molecules are treated as topological objects where atoms become the
vertices, and the bonds the edges of a molecular graph. The TOP descrip-
tors, such as atomic order, relative eletronegativity, length of covalent radius,
atomic mass, atomic and adjacent hydrogen mass, atomic polarity, atomic
radius, and atomic eletronegativity etc, can be easily calculated. The TOP
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descriptors can be used to evaluate structural similarity and diversity, making
them widely used in QSAR analysis.
Ideally the descriptors should contain relevant information on the compounds
and be few in number so that the subsequent analysis will not be too complex, but
larger descriptor sets are very popular in drug discovery.
1.3 Challenges of Drug Discovery Data
The characteristics of drug discovery data generate many challenges for QSAR
modeling:
1. Unbalanced response: although the data generated by HTS may have an
enormous number of tested compounds, active compounds are often very
rare.
2. Multiple mechanisms: the compound structure is complicated and may imply
many mechanisms leading to activity.
3. Subspace-governed activity: the multiple mechanisms are usually determined
by the low-dimensional subspaces of descriptors.
4. Nonlinear relationship: drug discovery data often involve threshold and non-
linear effects when the chemical structure is represented by a set of descriptors.
5. Measurement errors: large random or systematic measurement errors may be
present in the assays.
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As an open research area, QSAR modeling attracts researchers on many statis-
tical methods and techniques including simple methods such as linear regression,
and more advanced methods like neural networks (NN), Partial Least Squares and
recursive partitioning (RP, e.g. trees). Feng et al. (2003) built NN, PLS and RP
using four different sets of chemical descriptors (64 BCUT variables, 46 Constitu-
tional variables, 212 Property variables and 261 Topological variables in Table 1.1)
and compared their performance.
It is well accepted that more complicated methods (e.g. NN, PLS and RP)
should have more prediction power than linear regression to model a QSAR. Young
& Hawkins (1998) applied a recursive partitioning procedure, FIRM, to a large,
structure-activity data set and showed that different mechanisms of the data can
be discovered. A later study (Wang 2005) using the same data set compared K-
nearest neighbour classification (KNN), trees, neural networks, MARS (Friedman
1991), generalized additive models and logistic regression, concluding that KNN is
one of the best methods.
Due to the difficulty of data and variety of the problems, QSAR modeling con-
tinues to inspire people to find better predictive models.
1.4 Structure of the Thesis
In this thesis, two QSAR models are developed. Chapter 2 describes an algorithm-
based drug mining method: Cluster Structure-Activity Relationship analysis (CSARA).
Comparisons between CSARA and Recursive Partitioning are conducted to evalu-
ate the performance of CSARA. The second QSAR model is based on the idea of
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mixture discriminant analysis, which is described in Chapter 3. The motivations for
designing our special Constrained Mixture Discriminant Analysis (CMDA) model
are also given in Chapter 3. In Chapter 4, the first order CMDA model (CMDA1)
is discussed in detail. The degeneracy issue during the parameter estimation of
the CMDA1 model is our focus. A Multi-step Expectation-Maximization (EM)
algorithm is designed to handle the degeneracy problem. The other model-based
solution to degeneracy, Penalized Maximum Likelihood Estimation (PMLE), is in-
troduced in Chapter 5. The asymptotic consistency of the CMDA1 model is proved




2.1 QSAR Approaches: CSARA and RP
In theory, chemical compounds with similar structures will react with a biological
target in a similar way (Lajiness 1997). Further, if the compounds with similar
values of critical chemical descriptors can be grouped into one cluster, informa-
tion about the activity of all compounds in the cluster may be obtained by sim-
ply assaying one or a few compounds randomly picked from the cluster. Engels
& Venkatarangan (2001) suggested such a cluster-based approach for sequential
screening experiments, namely Cluster Structure-Activity Relationship Analysis
(CSARA). Even though Engels & Venkatarangan (2001) used several examples to
show how useful the CSARA method is in the process of active compound selection
compared to random selection, they did not compare CSARA with other QSAR
17
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methods, like recursive partioning (RP). As RP is a very popular QSAR approach
in drug discovery, it provides a good benchmark for comparison. In this chapter, we
follow the same basic CSARA algorithm, but our focus is to deepen understanding
of CSARA and explore its efficiency for screening drug data relative to RP.
The sequential screening framework described in Section 1.1.3 is applied here,
with both CSARA and RP taking the role of supervised learning approaches. With
the exception of Section 2.5, the response is assumed to be binary (active/inactive).
2.1.1 CSARA
The CSARA procedure is illustrated in Figure 2.1 and described as an algorithm
below.
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CSARA Algorithm
A. The entire compound library is available for sequential
screening.
B. Compounds are clustered using descriptors and one com-
pound is randomly selected from each cluster (shown in
black in Figure 2.1(B)).
C. The randomly selected compounds, one from each cluster,
are tested for biological activity. In Figure 2.1(C), the
compounds shown in black are active and those in gray
are inactive.
D. All the compounds in the clusters with an active compound
from (C) are assayed to get more accurate estimation of
their biological activities.
The CSARA algorithm is based on the belief that compounds with similar
chemical structures react with targets in a similar way. In Figure 2.1, CSARA
partitions the entire compound library into six clusters, and one representative of
each cluster is randomly selected and tested. If the selected compound is active,
we place all other compounds belonging to that cluster in the focused library for
the second round of HTS. However, if the selected compound is inactive, this would
suggest that the remaining compounds in the cluster are also inactive, and they are
not included in the second HTS. Although the illustration in Figure 2.1 has only
six clusters, CSARA would typically use hundreds or thousands of clusters.
In fact, CSARA is a two-stage sequential screening process. Steps B, C, and
D in the CSARA algorithm correspond to the key boxes in Figure 1.1: CSARA’s
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(D)(C)(B)(A)
Figure 2.1: The CSARA process. Adapted from Engels and Venkatarangan (2001).
Step B is selecting an initial sample of compounds or training data; Step C is HTS
to measure the activities of the initial sample; Step D combines QSAR analysis and
virtual screening in order to get the focused library.
In Step B, the whole compound library is partitioned into groups by a clustering
algorithm, using descriptors. The partitioned groups are then partly tested (here,
only one compound each group) and used to determine the activities of untested
compounds. CSARA uses both descriptors and biological activities of compounds
to analyze the relationship between molecular structures and biological activity, so
CSARA is a supervised learning algorithm.
K-means Algorithm
A critical part of CSARA is cluster analysis (Step B). Partitioning the entire com-
pound library into clusters can be approached with a wide variety of clustering
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algorithms (Dunbar 1997). Available algorithm-based methods of seeking clusters
can be categorized broadly as hierarchical methods and partitioning methods. In
this chapter, we use one popular partitioning method, K-means (MacQueen 1967).
For the K-means algorithm, K represents the required number of clusters that
must be supplied by the user. In general, the K-means algorithm works as follows:
1. Randomly choose K unique compounds with descriptor vectors, m1, . . . ,mK,
which serve as “centres” or “means” for the K clusters. Let C(1), . . . , C(K)
represent a partition of data indices 1, . . . , n into clusters 1, . . . , K.
2. Iterate the following steps until the cluster centres do not change with an
update:
(a) Update cluster memberships C(1), . . . , C(K) by allocating each compound
to the cluster with the closest centre.







xi for k = 1, . . . , K, (2.1)
where nk is the number of points in C
(k) and xi is a vector representing
descriptor variables of the ith point.
The aim of the K-means algorithm is to divide n points in p-dimensions into K
clusters so that the within-cluster sum of squares is minimized. The within-cluster
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where ‖ • ‖2 denotes squared Euclidean distance. The K-means algorithm is not
guaranteed to find the global minimum sum of squares (2.2). Instead, the K-means
algorithm will find a local optimum. Hartigan & Wong (1979) propose an improved
version of K-means such that the movement of a point from one cluster to another
will not reduce the within-cluster sum of squares. Although Hartigan & Wong’s
algorithm does not guarantee a global optimum, it tends to find better local optima.
Compared to other clustering algorithms, K-means is a fast algorithm because
distance calculations are only made from each point to the centers m1, . . . ,mK
rather than considering all pairwise distances. Also finding the nearest cluster for
each compound via Euclidean distance is a fast calculation. Due to its very quick
computability, K-means is an appealing method when dealing with large data sets,
especially those arising from HTS.
There are several issues needed to be considered when K-means is applied.
(1) Scaling
The K-means algorithm usually uses Euclidean distance to determine the cluster
center to which a compound is closest. The scaling of the descriptors does have an
effect on Euclidean distances. For the purposes of this thesis, the descriptors were
standardized by dividing them by their standard deviations.
(2) Unique starting values
A characteristic typical of HTS data can result in difficulty with the K-means
algorithm. According to Young, Lam & Welch (2002), HTS is an imprecise exercise,
which results in some compounds being assayed repeatedly. The replicated com-
pounds in the data set are a potential difficulty in the application of the K-means
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algorithm. The following scenario illustrates what can happen when replication is
present. Suppose compound i is assayed twice. In step 1 of the K-means algorithm,
it is possible to choose compound i to represent two different cluster centers. For
simplicity, we say cluster 1 and cluster 2 have center i. In step 2 of the algorithm,
the compound in cluster 1 will be reallocated to cluster 2 resulting in cluster 1
being empty. In this case, there are now only K − 1 clusters instead of the desired
K. To overcome this problem, only unique compounds should be selected as initial
centers. Then the replicated compounds can be allocated to the same clusters in
which their replicates reside.
(3) Multiple runs
Since the K-means algorithm gives different results for different starting values,
multiple runs are needed to find better optima. The random selection of initial
values make it likely that different runs will find different local optima.
2.1.2 Recursive Partitioning
Recursive Partitioning (RP) uses a tree-structured set of questions about the de-
scriptor variables to recursively divide the data into groups in which the response
variable is as homogeneous as possible. To build an RP model, the descriptor
space is recursively subdivided into nodes of a tree. To identify the best split for a
specific node, the algorithm considers all possible binary splits for each descriptor
variable and chooses the optimal one by some criterion (Breiman, Friedman, Ol-
shen & Stone 1984). This splitting is carried out recursively until some stopping
condition is reached. Stopping criteria can be employed directly to choose tree size
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(Hawkins & Kass 1982), or a large tree can be grown and then pruned (Breiman
et al. 1984).
An Example
Recursive partitioning can be visualized as a tree. Each segment of the tree is called
a node. Usually, a parent node is split into 2 descendant nodes. In Figure 2.2,
checkboard training data (Welch 2002) and a tree grown to this data are plotted.
The original node in which all of the data lie is called the root node. Class 0 has
40 of the 55 cases, i.e. 73%. If the tree growing algorithm is stopped at the root
node, the root node would be classified as class 0, the majority class. The root
node is split into two descendant nodes, which have X2 < 7.015 and X2 ≥ 7.015,
respectively. Ideally, the split should make each node as pure as possible. Here, the
descendants do not show much improvement in purity of the response, so another
split is needed before a big jump in purity appears.
The two descendants of the root node are themselves split to create their de-
scendants. The two descendants of the root’s left node, for example, are split based
on the value of X1: they have X1 < 6.39 and X1 ≥ 6.39, respectively, with 10%
and 62% class 1 objects, respectively. These nodes are closer to the ideal of all class
0 or all class 1. Neither of these needs further splitting; they are called terminal
nodes. Similarly, the root’s right descendant is split into two terminal nodes. Each
terminal node is classified according to its majority class. Note that the two de-
scendants of the root node are split using different cut-offs for X1 depending on the
value of X2, indicating that the tree can include interaction effects automatically.
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Classification tree for the checkerboard training data
Figure 2.2: Top: The scatter plot and partitioning of the checkerboard explanatory
variable space by the bottom tree. Class 0 and Class 1 training data are denoted
by “0” and “+”, respectively. Bottom: Classification tree for the checkerboard
training data.
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The top plot in Figure 2.2 also portrays the partitioning of the explanatory
variable space of the checkerboard training data. Each rectangle corresponds to
a terminal node. For example, the bottom-left rectangle corresponds to the first
terminal node with 27 Class 0 and 3 Class 1 cases.
Tree Size Selection
Our research initially considered a pruning approach. When pruning a tree, a
variety of criteria, including misclassification rate, the Gini index and entropy,
can be employed. For unbalanced classification problems such as drug discovery,
where one class (i.e. active class) is rare, misclassification rate is an inappropriate
pruning criterion. This is because we desire a tree that can rank compounds by the
probability that they will be active, rather than just classify them as active/inactive.
The performance measure we will use to assess tree performance is the hit
rate, which is the percentage of hits among those compounds selected. In order to
facilitate comparisons with CSARA, the number of compounds selected is matched
in each experiment with the number selected by CSARA.
Ideally, a tree would be grown and pruned according to the hit rate. However,
our goal is to compare “off-the-shelf” versions of tree growing algorithms with
CSARA, and hit rate is not a standard criterion for growing or pruning a tree. Thus
we choose the Gini index,
∑n
i=1 p̂i(1− p̂i), where p̂i is the predicted probability of
activity for observation i, as a surrogate measure for tree growing and pruning. The
Gini index is among the most appropriate measures since it encourages models to
accurately predict pi, the probability of activity for observation i, rather than just
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predict a class label.
Once a sequence of pruned trees has been generated using the surrogate pruning
criterion, predictions can be generated and the hit rate (our preferred performance
measure) can be evaluated for all trees in the sequence. Thus a cross-validated
measure of the hit rate will be obtained for each tree in the nested sequence of
trees. We explore two different ways of generating this hit rate: either calculating a
hit rate separately for each of the ten folds, and averaging them, or combining the
predictions from all ten validation sets, then ranking the compounds and generating
a single hit rate. Similar results were obtained using either strategy. All calculations
were carried out in R (R Development Core Team 2006), using the rpart library
(Therneau & Atkinson 2006).
In experiments with the AIDS Antiviral data with 64 BCUT descriptors (Sec-
tion 1.2.1), we made two unexpected discoveries with respect to pruning and tree
size:
1. Cross-validation, the most common method of selecting tree size, appears to
select a tree with too few nodes in unbalanced-class problems.
2. The largest trees yield the best (or near-optimal) out-of-sample predictive
accuracy.
In the remainder of this section, we outline the ideas behind these findings. A
consequence is that for the remainder of the chapter, we choose a large tree size
rather than use cross-validation, since this seems to produce the most competitive
RP models.
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To understand the two results, we first review cross-validation and cost-complexity
pruning. Breiman et al. (1984) presented a cross-validated cost-complexity pruning
approach to selecting the best tree size. Given a tree with size ‖T‖ (‖T‖ represents
the number of terminal nodes), the pruning criterion Rα is defined as:
Rα = C(T ) + α‖T‖ (2.3)
where C(T ) is a smaller-the-better measure such as the Gini index and α is called
the cost-complexity parameter. The term α‖T‖ is a penalty for the size of the
tree. Large values of α penalize big trees and lead to more pruning. Breiman et al.
(1984) showed that as α increased, there exists a well defined nested sequence of
pruned trees that optimize (2.3).
The tree with the best cross-validated cost-complexity would be chosen as fol-
lows: First, a large tree is grown using the training data. A nested sequence of
m pruned trees (with s1 < s2 < ... < sm terminal nodes) is generated, minimiz-
ing a cost-complexity criterion. In fact, we choose the cost-complexity parameters
to generate the nested sequence of trees. Since each cost-complexity parameter
corresponds to a specific tree size si, the sequence of the tree sizes is used in the
rest of the chapter for easier understanding. The goal is then to choose one tree
from this nested sequence (that is, choose s∗ ∈ s1, ...sm). This is accomplished by
cross-validation. For example, with 10-fold cross-validation, 10 different large trees
are grown and pruned, yielding 10 nested sequences, with sizes corresponding to
s1, ..., sm. Each of the 10 different trees is grown using 90% of the training data,
and holding out a different validation set of 10% of the training data. For each tree
size si, prediction errors are averaged across the 10 validation folds, and the best
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tree size s∗ is chosen so as to minimize this cross-validation error.
For the AIDS assay data and 64 BCUT descriptors, we generated 20 training
sets of 15,000 observations, about half of the data set, and for each set chose the
optimal tree size according to cross-validated hit rate. In order to see whether we
are choosing the right size, we “cheat” by also using the remaining (approximately
15,000) observations as a test set to choose the right tree size. The tree sizes chosen
by these two strategies are displayed in Figure 2.3. Cross-validation typically selects
a tree with between 1 and 100 terminal nodes, occasionally selecting a tree with
around 150 terminal nodes. In contrast, the test set reveals that the best tree size
is never below 60 terminal nodes, and is usually greater than 150 terminal nodes.
The choice by cross-validation of a too-small tree results in a decrease in prediction
accuracy for the test set, in comparison to the optimal tree size. Note that the use
of a test set to choose tree size is generally inappropriate, and is used here simply
to illustrate that cross-validation seems to select an inappropriate sized tree.
A possible reason for this discrepancy is the large number of “ties” that a
tree produces in its predictions for the probability of activity. All observations
falling in a specific terminal node of the tree will receive the same prediction.
Tie structure among the predictions can affect predictive accuracy in unbalanced
response problems where ranking is the goal. In cross-validation, since only 10%
of the data are predicted by a tree corresponding to each fold, and the trees are
slightly different for each fold, there are fewer ties in the predictions. This may
make a small tree appear to be a better performer under cross-validation, where
it seems to generate fewer ties, than for an independent test set, where one tree is






























Figure 2.3: Histograms of the tree sizes chosen by (a) cross validation and (b)
performance on an independent test set.
generated from all the training data, with more ties in predictions.
2.2 Evaluation Plan for CSARA and RP
In Section 2.2.1 we describe three strategies for data sampling/analysis based on
CSARA, RP, and a hybrid method. We also discuss a performance metric for their
evaluation.
2.2.1 Three Sampling/Analysis Strategies and Their Eval-
uation
All three strategies to be described will be evaluated in terms of their performance
in identifying active compounds in the second round of HTS.
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Specifically, we will use the hit rate (HR), which is the proportion of compounds
identified as biologically active via an assay among a specified group of compounds
selected for screening, i.e. active ÷ selected. As CSARA is a two-stage process of
sequential screening, hits (active compounds) and hence the hit rate come from
both the first and the second screens. A tree generated by RP, however, is used to
make predictions and hence choose compounds for only the second screen. Thus, all
comparisons of HR will be made only for the second screen. The assay results from
the first screen are treated as “training” data, and those from the second screen
are treated as “test” data. Nonetheless, the performance of RP will depend on the
training data used to fit it. Thus, we will also consider the role of training data in
defining strategies.
Two distinct methods are used to sample training data:
Methods for Sampling Training Data
Cluster: The compound collection is clustered into K clusters,
and one compound is randomly chosen from each cluster.
This is Step B of the CSARA algorithm, illustrated in
Figure 2.1(B).
Random: K compounds are chosen completely at random
(without replacement) from the collection.
The Cluster method is a component of CSARA, but it can also be used to
generate training data for RP. It allows us to evaluate the differences between
CSARA and RP when the same training data are used in modeling the QSAR. The
Random method can be used only for RP. It will allow us to assess the usefulness
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of a training sample designed to be diverse versus a random selection.
Hence, there are three different data sampling/analysis strategies:
Three Sampling/Analysis Strategies
CSARA: All steps of the CSARA method as described in Sec-
tion 2.1.1.
Cluster/RP: The Cluster sampling method is used to select
the initial sample set, an RP tree is trained on this set,
and predictions from the tree model are used to choose
the follow-up sample.
Random/RP: The Random sampling method is used to se-
lect the initial sample set, an RP tree is trained on this set,
and predictions from the tree model are used to choose
the follow-up sample.
The comparisons of interest are CSARA versus Cluster/RP and Random/RP,
to understand the impact of the QSAR modeling method, and Cluster/RP versus
Random/RP to understand the impact of the sampling of the training set.
2.3 Experiments and Results
2.3.1 Yeast Data
First, we apply CSARA, Cluster/RP and Random/RP to the Yeast data. We need
to specify K, the number of clusters used to generate the first screen. Since one
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First Screen Second Screen (CSARA) Cluster/RP Random/RP
Trial Hits HR (%) # compounds Hits HR (%) Hits HR (%) Hits HR (%)
1 243 8.1 5,648 874 15.5 819 14.5 676 12.0
2 250 8.3 5,720 861 15.1 870 15.2 753 13.2
3 261 8.7 6,060 841 13.9 678 11.2 788 13.0
4 262 8.7 6,272 1020 16.3 917 14.6 777 12.4
Ave. 254 8.47 5,925 899 15.2 821 13.9 749 12.6
Table 2.1: Results for the Yeast data and K = 3, 000 clusters
compound from each cluster will be assayed, the resultant training set will have K
observations to be used for training data: We take K = 3, 000, 7,000 and 15,000.
Because all methods considered rely on some form of randomization to select the
training data, four trials are run at each of the three levels of K. The six BCUT
descriptors described in Section 1.2 are used.
The results are presented in Tables 2.1–2.3. As the results follow similar patterns
across values of K and the four trials, we explain in detail only the first row of Table
2.1. The first column is the trial index. The second and third columns correspond
to the first screen using Steps A–C of the CSARA method. After the first screen,
there are 243 hits in the training set, giving a hit rate of 243/3, 000 = 8.1%.
The fourth to sixth columns give results from the second HTS using Step D of
CSARA: All compounds in the active clusters (not including those in the first
screen) are treated as the test data for the second round HTS. In this example,
5648 compounds are in the test data, there are 874 hits, and consequently the hit
rate is 874/5, 648 = 15.5%.
The seventh and eighth columns give results from the second screen using Clus-
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ter/RP. In the first row of Table 2.1, Cluster/RP selects the 5,648 compounds with
highest predicted probabilities of being active (the size of the test set is matched to
CSARA’s). Roughly 819 or 14.5% are active. The same technique of selecting for
the second screen is used for Random/RP in columns 9–10, but the training data
are K = 3, 000 randomly chosen compounds. The last row of Tables 2.1–2.3 gives
average values across the four trials/test splits.
For tree models, calculation of the number of hits is complicated by the presence
of many tied predictions. All test points falling in the same terminal node will
receive the same predicted probability of activity. For example, suppose the best
14 nodes give us 5,448 compounds from the test set, and the 15th best node has an
additional 300 test set compounds. We need to select 200 of these 300 compounds
to give the desired 5,648 compounds. We deal with this problem by reporting an
expected number of hits under random sampling of 200 compounds from the 300
available in the node. This is equivalent to linear interpolation of number of hits
between the two nodes.
In Tables 2.1–2.3, within each row, CSARA and Cluster/RP can be compared
since they have the same training data set. Comparing Random/RP with CSARA
or Cluster/RP is not meaningful within a row because they have different training
sets. Comparisons using the “average” row are valid between all three methods.
The results given in Tables 2.1–2.3 can be summarized as follows:
• As K increases, the hit rate in the test set also increases. This makes intuitive
sense because a larger training set gives more information to the tree and
clustering algorithms, enabling them to uncover the QSAR within the HTS
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First Screen Second Screen (CSARA) Cluster/RP Random/RP
Trial Hits HR (%) # compounds Hits HR (%) Hits HR (%) Hits HR (%)
1 584 8.3 5,783 1,056 18.3 888 15.4 960 16.6
2 584 8.3 5,785 1,069 18.5 938 16.2 857 14.8
3 580 8.3 5,515 1,023 18.6 872 15.8 809 14.7
4 583 8.3 5,735 1,053 18.4 890 18.4 877 15.3
Ave. 583 8.3 5705 1,050 18.4 897 16.4 876 15.3
Table 2.2: Results for the Yeast data and K = 7, 000 clusters
First Screen Second Screen (CSARA) Cluster/RP Random/RP
Trial Hits HR (%) # compounds Hits HR (%) Hits HR (%) Hits HR (%)
1 1,182 7.9 4,771 1,066 22.3 898 18.8 845 17.7
2 1,321 8.8 5,417 1,110 20.5 928 17.1 955 17.6
3 1,259 8.4 5,197 1,064 20.5 871 16.8 894 17.2
4 1,286 8.6 5,099 1,057 20.7 871 17.1 860 16.9
Ave. 1,262 8.4 5,121 1074 21.0 892 17.5 889 17.4
Table 2.3: Results for the Yeast data and K = 15, 000 clusters
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CSARA Cluster/RP Random/RP
K Mean HR (se) Mean HR (se) Mean HR (se)
3,000 20.3% (.6%) 15.6% (.7%) 15.6% (.8%)
5,000 24.5% (.7%) 19.5% (.8%) 18.0% (.6%)
7,000 26.4% (.4%) 21.3% (.8%) 20.6% (.5%)
10,000 31.6% (.5%) 26.7% (.7%) 22.5% (.5%)
15,000 36.6% (.5%) 30.0% (.5%) 24.7% (.5%)
Table 2.4: Results for the AIDS data
data. Also, as K increases the change in the hit rate is larger for CSARA
than for Random/RP and Cluster/RP.
• Whatever K is chosen, CSARA always has a higher hit rate than Cluster/RP
and Random/RP. This indicates that CSARA outperforms Cluster/RP and
Random/RP.
2.3.2 AIDS Data
A similar analysis is carried out for the AIDS data, but with K = 3, 000, 5000,
7,000, 10,000 and 15,000, and 20 trials (training sets) are used. The descriptor set
is six BCUTs and there are 29, 812 compounds.
Instead of presenting results for each trial, as in Tables 2.1–2.3, we report in
Table 2.4 averages and standard errors across the 20 test sets. Since each row
represents an average over multiple training sets, all three methods can be compared
within a row.
Table 2.4 shows that:
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• The standard errors of the hit rate are very small, implying that 20 trials
are sufficient to compare the mean hit rates of the three sampling/analysis
strategies.
• For all values of K considered, the mean hit rate of CSARA is consistently
larger than that of Cluster/RP or Random/RP. Thus, CSARA method is
competitive and efficient relative to RP for identifying active compounds here.
• Cluster/RP outperforms Random/RP, particularly for larger values of K: A
diverse training set is advantageous here.
Formal statistical tests, i.e., paired t-tests for CSARA versus Cluster/RP and
unpaired t-tests for the other comparisons, confirm the above findings at a 5% sig-
nificance level. The differences in mean HR are statistically significant for CSARA
against either RP competitor for all values of K, and for Cluster/RP against Ran-
dom/RP for K = 10, 000 and 15, 000.
2.3.3 Adding Irrelevant Descriptors
In order to test the stability of CSARA and RP methods, we carry out a new ex-
periment on the AIDS data adding several irrelevant or “junk” descriptor variables
to the six BCUT descriptors when modeling the AIDS data. The values of the first
new, irrelevant descriptor are generated by randomly permuting the values of the
first BCUT, the second irrelevant variable is generated in the same way from the
second BCUT, and so on. Different permutations are used for each variable. We
take K = 15, 000 in this experiment.
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# Irrelevant CSARA Cluster/RP Random/RP
Descriptors Mean HR (se) Mean HR (se) Mean HR (se)
0 36.6 (0.531) 30.0 (0.522) 24.7 (0.453)
1 26.2 (1.93) 28.7 (1.50) 24.1 (0.85)
2 20.5 (0.53) 26.8 (0.74) 23.8 (1.68)
3 14.0 (1.84) 23.7 (0.42) 22.8 (1.82)
4 12.1 (0.59) 23.2 (0.69) 25.7 (1.51)
5 9.5 (0.68) 23.6 (2.41) 21.3 (1.55)
6 8.2 (0.97) 19.5 (2.05) 20.5 (0.59)
Table 2.5: Mean hit rates and standard errors (%) for the AIDS data and K =
15, 000 when irrelevant descriptors are added to the six BCUTs
Table 2.5 illustrates the effect of adding 1–6 junk variables. The hit rates re-
ported are means over four trials. With more irrelevant descriptors, the mean hit
rate of CSARA decreases much more quickly than that of Cluster/RP or Ran-
dom/RP. Among these three methods, Random/RP is the most stable. RP has
built-in variable selection due to choosing a variable at each split according to an
optimality criterion (here the gini index). CSARA has no such capability, as all
descriptors are included in the distance metric for clustering. Similarly, the ben-
efit due to clustering in selection of a training set for RP diminishes with more
irrelevant variables.
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2.4 Experiments with High-dimensional Descrip-
tor Sets
In order to understand how CSARA performs with higher-dimensional descriptor
sets, we make comparisons between CSARA, Cluster/RP, and Random/RP using
the AIDS assay data and four further descriptor sets. The four sets, summarized
earlier in Table 1.1, are BCUT (64 variables), Constitutional (46 variables), Prop-
erty (212 variables) and Topological (261 variables).
As before, we run 20 trials for different values of K and calculate the mean hit
rates. Mean hit rates are plotted against K in Figure 2.4
Figure 2.4 shows that CSARA outperforms Cluster/RP and Random/RP. These
high-dimensional results may seem to conflict with the experiment in Section 2.3.3,
where CSARA performance degraded quickly with the addition of further, irrele-
vant descriptors. CSARA’s strong performance here with high-dimensional sets is
probably a reflection of the quality of the sets, where all variables may be at least
weakly informative. In contrast, irrelevant variables are completely unrelated to
activity.
Table 2.6 displays the significance levels for tests of a difference in mean HR,
comparing CSARA, Cluster/RP, and Random/RP pairwise for each of the four de-
scriptor sets. It is clear that CSARA has a significantly larger mean HR than Clus-
ter/RP or Random/RP, and that Cluster/RP performs better than Random/RP
as K increases. A paired t-test was used to compare CSARA with Cluster/RP, and
a two-sample t-test for other comparisons.































































































Figure 2.4: Mean hit rate versus K for CSARA (⋆ · · · ⋆), Cluster/RP (◦ · · · ◦), and
Random/RP (⋄ · · · ⋄) for the AIDS data with four high-dimensional descriptor sets.
2.5 Application of CSARA to a Continuous As-
say Response
As mentioned in Section 1.2.1, growth inhibition (potency) of compounds was orig-
inally measured as a continuous response for the Yeast assay. “Active” and “inac-
tive” labels were obtained by thresholding the response. Here, we adapt CSARA
for a continuous response, and compare performance with RP methods.
Step D of the CSARA algorithm in Section 2.1.1 is adapted as follows. Each
cluster is scored according to the potency of the compound randomly sampled from
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CSARA vs. Cluster/RP CSARA vs. Random/RP Cluster/RP vs. Random/RP
K BCUT CON PROP TOP BCUT CON PROP TOP BCUT CON PROP TOP
3,000 *** *** *** *** *** *** *** ***
5,000 *** *** *** *** *** *** *** ***
7,000 *** *** *** *** *** *** *** ***
10,000 *** *** *** *** *** *** *** *** ** *
15,000 *** *** *** *** *** *** *** *** *** *** *** ***
Table 2.6: Hypothesis tests comparing mean HR for three sampling/analysis strate-
gies when applied to the AIDS data with four descriptor sets: 64 BCUT descrip-
tors, 46 Constitutional descriptors, 212 Property descriptors and 261 Topological
descriptors. Differences in mean HR significant at the 5%, 1%, and 0.1% levels are
denoted by *, **, and ***, respectively.
it for assay. All compounds in the highest scoring cluster are chosen first for the
second-round assay, then those in the second-highest scoring cluster, and so on.
Building an RP regression tree for a continuous response is well known (Breiman
et al. 1984). Comparisons are carried out with the six BCUT descriptors and
K = 3, 000.
The results are shown graphically in Figure 2.5. The average potency of the
selected compounds is plotted against the number of compounds selected. A curve
that is high at the left and decreases gradually would indicate good ability to
identify high potency compounds.
Several observations can be made on the basis of Figure 2.5:
• Up to about 1000 compounds selected, there is substantial improvement over
random selection, which would correspond to a horizontal line at a height of
approximately 8%.
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Figure 2.5: Average potency (%) of selected compounds versus the number of
compounds selected for CSARA, Cluster/RP, and Random/RP, when K = 3, 000.
The symbols on the curves show where selection would stop if a predicted potency
larger than 70% inhibition is required.
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• Compared with the RP methods, performance of CSARA falls off faster with
the number of compounds selected.
• If 70% predicted inhibition is used as a cut-off, CSARA chooses more com-
pounds for the second screen compared with the RP strategies.
Similar results (not shown) are obtained for K = 10, 000, except that all strategies,
not surprisingly, return higher average potencies for the first 10,000 compounds
selected with a larger K.
2.6 Discussion
The main aim of this chapter is exploring the properties of CSARA. Two data
sets are analyzed to help evaluate the differences between CSARA and RP. The
results suggest that CSARA outperforms RP models in selecting more hits. RP
trees are trained to give overall good prediction, giving equal weight to both active
and inactive compounds. In contrast, in its very simple analysis of the first-round
training data, CSARA gives heavy weight (100%) to active compounds and no
weight to inactive compounds. Thus, CSARA may be a more appropriate method
for drug discovery data sets where actives are rare.
However, the largest limitation with CSARA is its instability. When there are
many irrelevant descriptors, the effectiveness of CSARA decreases. In the presence
of many potential irrelevant descriptors, variable selection may need to be carried
out first. Here the term “irrelevant” variable refers to those that have no relation-
ship with the biological assay and hence have a negative impact on QSAR model
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training and prediction. For the AIDS assay data and the four high-dimensional
descriptor sets used in the chapter, some experiments have been done to test if there
is any performance improvement of CSARA, Cluster/RP, and Random/RP using
the important variables identified by Partitionator from www.goldenhelix.com. No
significant improvements were found for the three approaches. It is not surprising
that the performance of Cluster/RP and Random/RP is not improved by variable
selection, as trees can automatically select important variables at each split. Here
we need to emphasize that the variables that are not chosen as important are not
necessarily irrelevant. They seemingly do not help in the prediction of biological
activity, but they are not harmful to prediction either, possibly because of cor-
relations with other variables. This may explain why variable selection does not
improve CSARA for these descriptor sets.
One potential shortcoming of CSARA is the lack of control over the number of
compounds selected for a second HTS. In applications where the categorical activity
is formed from an underlying continuous response, the methods in Section 2.5 may
circumvent this difficulty.
The results in Section 2.5 also provide much insight into the comparisons be-
tween CSARA and the RP methods. RP trees may be effective in choosing a
relatively small number of second-screen (test) compounds. In most of the experi-
ments in this chapter, however, we matched the number of test compounds across
CSARA and the RP methods, forcing RP to select a large number of compounds
if CSARA does. When control over the size of the second screen is made possible
for CSARA too (by working with a continuous assay measurement), RP methods
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In Chapter 2, CSARA successfully separated data into different classes and out-
performed tree models. An essential component of CSARA is its use of clustering
to subdivide the data into groups more likely to be active. This motivates us to
consider using mixture models, a model-based clustering technique, to classify data.
Although mixture models are an unsupervised learning technique, they can be used
in discriminative models, in which the joint distributions of descriptors are modeled
as a mixture, conditioned on the response class.
Section 3.1 gives an overview of discriminant analysis approaches. Since mix-
ture models will be used as a component of a discriminant analysis method, an
introduction to mixture models is given in Section 3.2. An introduction to mixture
discriminant analysis is presented in Section 3.3, and some motivation for the use
of mixture discriminant analysis method in drug discovery is given in Section 3.4.
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3.1 Overview of Discriminant Analysis
Discriminant Analysis refers to a variety of models designed for classification (i.e.
the assignment of the data into predefined classes). In general, the number of
classes is assumed to be known. Many discriminant analysis methods are proba-
bilistic, based on the assumption that the observations in the kth class are generated
by a probability distribution specific to that class f(x;Ψk), also called the class-
conditional distribution. Discriminant analysis models differ essentially in their
assumptions about the class-conditional distribution.
If τk is the proportion of members of the population that are in class k, Bayes’
theorem says that the posterior probability that an observation with feature vector
x belongs to class k is




where K is the total number of classes in the data. Then x is assigned to the class
with the highest posterior probability.
The most common discriminant analysis method, linear discriminant analysis
(LDA), assumes that the class conditional distributions are P -variate normal with
mean vectors µk and common covariance matrix Σ. When the covariance matrices
Σk’s are not assumed equal, the method is called quadratic discriminant analysis
(QDA). The parameters µk and Σk are unknown and must be estimated from a
training set consisting of (xi, yi), i = 1, . . . , n, where xi is a vector-valued measure-
ment and yi ∈ {1, 2, . . . , K} is a class indicator for observation i. The parameters
are generally chosen to maximize the likelihood of the training sample. This leads
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to the maximum likelihood estimates





, 1 ≤ k ≤ K. (3.2)
where nk =
∑n



















(xi − x̄k)(xi − x̄k)T
nk
, 1 ≤ k ≤ K. (3.4)
Friedman (1989) considered linear and quadratic discriminant analysis in a small
sample, high-dimensional setting. He proposed Regularized Discriminant Analysis
(RDA), which employs an alternative to the usual maximum likelihood estimates for
the covariance matrices. RDA specifies the value of a complexity parameter and
of a shrinkage parameter to design an intermediate classifier between the linear,
the quadratic, and the nearest-means classifiers. RDA performs well but does not
provide easily interpretable classification rules.
Bensmail & Celeux (1996) proposed an alternative approach for discriminant
analysis problem, Eigenvalue Decomposition Discriminant Analysis (EDDA). EDDA
is based on the reparameterization of the covariance matrix Σk of class k in terms of
its eigenvalue decomposition Σk = λkDkAkDk
T (Banfield & Raftery 1993). Here
λk specifies the volume of density contours of class k; Ak, the diagonal matrix of
eigenvalues, specifies the shape of class k; and Dk, the eigenvectors, specifies its ori-
entation. Variations on constraints concerning volumes, shapes and orientations λk,
Ak and Dk lead to 14 discrimination models of interest. After the class-conditional
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distributions are determined, observations are assigned to the class with the largest
posterior probability (3.1).
3.2 Mixture Models
Finite mixture models have wide applications in the scientific literature. They
provide a mathematical approach to the statistical modeling of a wide variety of
random phenomena. Mixture distributions are typically used to model data in
which each observation is assumed to have arisen from one of J different groups,
each group being modeled by a probability density belonging to a parametric fam-
ily. Membership in the groups is not observed. Mixture models are suitable for
clustering observations together into groups.
The first attempts to analyze mixture models are often attributed to Pearson
(1894), who applied mixture models to data on the dimensions of crabs. Since
then, mixture models have been used in a large range of applications. McLachlan
& Basford (1988) highlighted the important role of mixture models in the field
of cluster analysis. In the cluster analysis framework, the data is supposed to be
sampled from some population described by a probability density function. This
density function is characterized by a parameterized model that is a mixture of
component density functions and each component density function describes one of
the clusters.
In general, let f(x;Ψ) be a parametric density function with respect to some σ-
finite measure and parameter space ⊖, which is usually a subset of some Euclidean
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where J is the number of components or the order of the model, and Ψ represents all
the parameters in the above density function and includes {π1, . . . , πJ−1;Φ1, . . . ,ΦJ}.
Φj is the parameter of the j
th component density, and πj is the mixing proportion
of the jth component density.
There are several approaches to the estimation of the parameters of mixture
models. As discussed by McLachlan & Peel (2000), such approaches include graph-
ical methods, methods of moments, minimum-distance methods, maximum likeli-
hood estimation (MLE) and Bayesian methods. Maximum likelihood estimation
is by far the most commonly used approach. Such popularity is mainly due to
the advent of the Expectation-Maximization (EM) algorithm (Dempster, Laird &
Rubin 1977), which is an iterative method that locally maximizes the likelihood
function in an efficient way. The EM algorithm not only considerably simplifies the
MLE approach to mixture parameter estimation by viewing it as an incomplete-
data problem, but also gives a theoretical basis for the convergence properties of
mixture problems.
Therefore, maximum likelihood estimation via the EM algorithm is the approach
we consider in the following chapters.
A popular choice of component density is the normal distribution. The earlier
researchers who have studied mixtures of normal distributions include Day (1969),
Wolfe (1970), Marriott (1975) and Symons (1981). Mixtures of other distributions
that have been considered by other researchers include exponential (Rider 1961),
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Beta (Bremmer 1978), Weibull (Kao 1959) and Binomial (Blischke 1962, Rider
1962, Blischke 1964). In the following chapters, mixtures of normal distributions
will be our focus.
In the next section, we will focus on discussion of mixture discriminant analysis,
in which mixtures are used within each response class.
3.3 Mixture Discriminant Analysis
An alternative model-based approach to generalizing LDA and QDA is to allow the





πjkMV N(x; µjk,Σjk). (3.6)
Here k indexes class and j the mixture component within class. Ψk represents all
the parameters within class k, i.e. Ψk = {π1k, . . . , πJk−1k; µ1k, . . . , µJkk;Σ1k, . . . ,
ΣJkk}. Here, and throughout the remainder of the thesis, we denote a multivariate
normal density with MV N(x; µ,Σ). A univariate normal density will be denoted
N(x; µ, σ). The idea of mixture models has been suggested a number of times in
the literature (McLachlan 1992), and is the basis of Mixture Discriminant Analysis
or MDA (Hastie & Tibshirani 1996). In developing MDA, Hastie & Tibshirani
(1996) made two assumptions: (i) that all of the component covariance matri-
ces are the same, i.e. Σjk = Σ for each j, k; and (ii) that the number of mixture
components is known in advance for each class. Hastie & Tibshirani (1996) also pro-
posed several extensions of the model under these assumptions. Moreover, Fraley
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& Raftery (2002) extended MDA by relaxing assumptions (i) and (ii) and apply-
ing model-based clustering to the members of each class in the training set. This
would allow the component covariance matrices to vary, both within and between
classes. The data would then determine which parametrization of the covariance
matrix and which number of mixture components is best suited to each class. This
generalization of MDA is refered as Model-based Clustering Discriminant Analysis
(MclustDA).
The basic idea of the model-based discriminant analysis methods described here
is to allow more flexibility than the traditional methods, LDA and QDA. Also
mixture-based MDA and MclustDA further improve on EDDA by expanding the
discriminant model from a single Gaussian component to a mixture.
However, none of the above discriminant methods considers exploring subsets
of predictors, which is becoming critical for higher-dimensional drug discovery data
due to the subset-governed activities. In our new form of mixture discriminant
analysis, µjk and Σjk share some common parameters, called global parameters in
our model. Each component is dominated by one element of the descriptor vector,
so the structure of the new mixture discriminant analysis model is designed to
explore subsets of descriptor space.
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3.4 Motivation of Application of Mixture Model
in Drug Discovery
There are numerous papers on the application of mixture models, but there are
fewer applications of mixture models in drug discovery. There are several consid-
erations motivating us to use mixture models to model drug discovery data.
These considerations come from the HTS data sets themselves. Although we
have mentioned these ideas in Section 1.3, we develop them further here:
(1) Because of the complicated relationship between descriptors and biological ac-
tivity of compounds, it is difficult to use a single mathematical model to
capture the characteristics of the entire data set. As we have discovered in
the first part of the thesis, the active compounds can usually be divided into
several clusters. The active compounds do have the same effect on the drug
target, but across clusters, they can have very different descriptors leading
into activities. Special models, such as mixture models are needed to model
several different mechanisms simultaneously. This is the multiple mechanism
problem.
(2) The biological activity is usually governed by a small number of descriptors.
Due to the flexibility of mixture models, making some modifications on mix-
ture models would allow us to explore subsets of descriptors.
(3) There are many descriptors, which are often highly correlated. Again, CSARA
and tree models can not take into account the covariance of descriptors, but
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mixture models can. For example, the covariance matrix of a multivariate
normal distribution can describe such properties of descriptors.
In the thesis, we focus on the first and second considerations. Chapter 4 presents
our specially designed mixture discriminant analysis model, Constrained Mixture
Discriminant Analysis (CMDA). The CMDA first order model or CMDA1 is dis-
cussed in detail. A frequently-occurring problem arises, in which the EM algorithm
can produce “degenerate” estimates with some variances equal to zero. This occurs
because the likelihood for a mixture model with unknown scale parameters is un-
bounded. Therefore, a Multi-step EM algorithm is designed to solve this problem
in Chapter 4. In Chapter 5, penalized maximum likelihood estimation approach to
solve the degeneracy problem is suggested and discussed. A consistency proof of
the penalized maximum likelihood estimate (PMLE) for the CMDA1 model with a





Statistical learning in drug discovery seeks a good classifier that separates chemical
compounds into active and inactive classes. However, the characteristics of drug
data imply many challenges for structure modeling and identification of active com-
pounds (Section 1.3 and Section 3.4). Due to the characteristics of drug discovery
data sets, we develop the Constrained Mixture Discriminant Analysis (CMDA)
model, which is designed to catch multiple mechanisms that lead to activity, ex-
plore the subsets of descriptors and be easily interpreted (e.g. identify important
descriptors).
The approach to classification taken here is to model the within-class densities
of the predictors f(x|Class k) by constrained mixture models. Then the class pos-
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terior probabilities f(Class k|x) can be obtained via Bayes’ theorem as described
in Section 3.1.
Before the model is given, we review some notation introduced earlier in Chap-
ter 3:
• y is the response variable taking K categorical levels, which is biological
activity in drug discovery. Usually, in drug discovery, K = 2, i.e. the active
and inactive classes.
• x is a vector of descriptors from an observation, which is assumed to come
from a P -dimensional real-valued sample space, i.e. x = (x1, . . . , xP ) ∈ ℜP .
• k = 1, . . . , K indexes the K classes.
• j = 1, . . . , Jk indexes components in each class. Jk is the total number of
components in kth class.
• i = 1, . . . , n indexes observations in the sample.
The CMDA model is based on the belief that the influence of descriptor vector x
on biological activity y is through low-dimensional subspaces (Lam 2001). We shall
express the class-conditional density of descriptor vector x as an additive model
including low-dimensional functions. This is designed to explore the subspaces of
descriptors and identify the multiple mechanisms that may cause activity.






Constrained Mixture Discriminant Analysis 57




In the CMDA model, the multivariate density of any component f(x;Φjk) will
be composed of products of univariate or bivariate density functions. Types of
f(x;Φjk) that could be considered, when P = 4 and the normal densities are used,
include:
1. f(x;Φjk) = N(x1; µ1j, σ1j)N(x2; µ2j, σ2j)N(x3; µ3j , σ3j)N(x4; µ4j, σ4j). The
components of x (xl’s) are independent and unrelated to the class label k.
2. f(x;Φjk) = N(xj ; µjk, σjk)
∏4
m6=j N(xm; µm, σm), i.e. one element of the de-
scriptor vector is conditionally independent of other elements given the class
label k and the mixture component label j. Also N(xj ; µjk, σjk) is a class
specific density with parameters depending on both j and k. There is a
connection between variables and the component in this type of component
density, i.e. component f(x;Φjk) is determined by variable xj via the func-
tion N(xj ; µjk, σjk).
3. f(x;Φjk) = MV N(xl, xl′ ; µjk,Σjk)
∏
m6=l&l
′ N(xm; µm, σm), which means there
are two elements of the descriptor vector that have a jointly dependent rela-
tionship given the class label k. Here, j corresponds to the pair (l, l
′
).
4. f(x;Φjk)’s can be a combination of above forms, for example
f(x;Φjk) = N(x1; µ1, σ1)N(x2; µjk, σjk)MV N(x3, x4; µjk,Σjk) . . . (4.2)
Our primary focus will be on model of form 2. Form 3 will also be considered.
Although we use bivariate distributions to represent joint dependence in Form 3, in
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general, these need not be bivariate. More explicit parameterizations will be given
in the next section.
We first consider the CMDA First Order Model, or the CMDA1 model,




N(xj ; µj, σj)
+ π2kN(x2; µ2k, σ2k)
∏
j 6=2
N(xj ; µj, σj) + . . .
+ πPkN(xP ; µPk, σPk)
∏
j 6=P
N(xj ; µj, σj).
In the following section, a detailed discussion of the CMDA1 model is given.
4.2 The CMDA First Order Model (CMDA1)
For a general case, including the parameters in the density function, the CMDA1









where h is some univariate density function with parameters Φ̄ and
Ψk = (π1k, . . . , π(P−1)k, Φ̄1k, . . . , Φ̄Pk)
T
represents all the unknown parameters specific to class k. The model also has
global parameters ΨG = (Φ̄1, . . . , Φ̄P )
T , which are used within all classes. For
later notational convenience, we use a “G” subscript on Ψ to denote a collection
of “global” parameters, and a “k” subscript on Ψ to index parameters specific
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to class k. Here and throughout the thesis, we use a single subscript (e.g. Φ̄l) to
denote “global” parameters and double subscripts (e.g. Φ̄jk) to denote class-specific
parameters. Then all parameters are denoted as Ψ = (Ψ1, . . . ,ΨK, ΨG)
T .
There are some interpretations for the CMDA1 model:
• Each component density is a product of P univariate density functions, which
suggests the CMDA1 model is based on an assumption that all the descriptors
are independent given a class and a component. These components could be
thought of as corresponding to specific mechanisms.
• Since the CMDA1 model explores all the 1-dimensional subsets of the de-
scriptors, the number of components in each class equals P , the dimension
of x. That is, in the general form of the mixture model (4.1), Jk = P for
k = 1, . . . , K. Each component is primarily identified by only one element of
x, whose distribution depends on class labels, via the term h(xj ; Φ̄jk).
• There are two parts in each component density function: “h(xj ; Φ̄jk)”, the
class specific part and “h(xl; Φ̄l)”, the global part. In (4.3), h(xj ; Φ̄jk) varies
across both mixture components and classes while the h(xl; Φ̄l) terms in the
product remain the same across classes. The concept of global parameters
comes from the reality that the active compounds are rare in typical drug data.
It is hard to accurately estimate the parameters for the density function of
the rare class due to the small samples of active compounds. Using global
densities allows the estimation for the rare class to borrow strength across
classes.
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• There are fewer parameters to be estimated for the CMDA1 model compared
to an unconstrained case, in which each component has distinct parameter
values. For instance, if h(·) in (4.3) are assumed to be normal density distri-





πjkN(xj ; µjk, σjk)
∏
l 6=j
N(xl; µl, σl). (4.4)
There are in total (3P − 1)×K + 2P parameters (there are (P − 1)×K π’s,
P ×K class specific µ’s, P ×K class specific σ’s, P global µ’s and P global
σ’s). In comparison, the traditional mixture model has (2P 2 + P − 1) × K
parameters to be estimated under the same independence assumption. The





πjkMV N(x; µjk,Σjk), (4.5)
There are no constraints on the mean vectors (µjk’s), and the covariance
matrices (Σjk’s) are assumed to be diagonal.
Figure 4.1 illustrates the basic idea behind the CMDA1 model. The two-
dimensional data are simulated from a CMDA1 model. The blue and red points
represent two different classes. Consider the two clusters (one red and one blue) in
the top-left corner of the plot: these two clusters share a common mean (µ2) along
the x2 direction, and different means (µ11, µ21) along the x1 direction. Hence these
two clusters can be distinguished using only the descriptor x1. The parameter µ2
is called a global parameter, while µ11 and µ21 are local parameters. The same
interpretation is applied to the other two clusters, with the global parameters in
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µ11, µ12, µ21, µ22
global parameters
µ1, µ2
Figure 4.1: Example of the CMDA1 model. Red and blue points indicate class
membership.
dimension x1. For illustrative purpose, this plot focuses on the location parameters
of the CMDA1 model. As (4.4) indicates, the variances are similarly parameterized.
4.3 The Expectation-Maximization (EM) Algo-
rithm and Mixture Models
The asymptotic efficiency of maximum likelihood estimation makes it one of the
most commonly used estimation approaches (Lindsay 1995). Maximum likelihood
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estimation became popular especially after Dempster et al. (1977) introduced the
EM algorithm, which can solve difficult MLE problems. Since its inception, the EM
algorithm has attracted considerable attention and has been the subject of much
research. The EM algorithm greatly stimulated interest in the use of finite mixture
distributions to model heterogenerous data. This is because the fitting of mixture
models by maximum likelihood is simplified considerably by the EM algorithm.
Since the EM algorithm will be used extensively in estimating the CMDA1
model, we review it for the simpler case of a g−component mixture, i.e. f(x;Ψ) =
∑g
j=1 πjf(x;Φj) where Ψ = (π1, . . . , πg−1;Φ1, . . . ,Φg). The CMDA1 model will be
considered later in Section 4.4.
In the EM framework, the observed data x = (xT1 , . . . ,x
T
n )
T is viewed as being




which is assumed unknown. Each xTi is conceptualized as having arisen from one
of the components of the mixture model. If the mixture model has g components,
zi is a g−dimensional vector with zij = (zi)j = 1 or 0, according to whether xi did
or did not arise from the jth component of the mixture (i = 1, . . . , n; j = 1, . . . , g).
Exactly one element of zi will be 1. The complete-data is defined as
xc = (x
T , zT )T , (4.6)












zij{log πj + log f(xi;Φj)}. (4.7)
Constrained Mixture Discriminant Analysis 63
4.3.1 E-Step
The EM algorithm is applied to this problem by treating the zij as missing data.
It proceeds iteratively in two steps, E (for expectation) and M (for maximization).
The missing data (zij) are handled by the E-step, which takes the conditional
expectation of the complete-data log likelihood, lc(Ψ) in (4.7), given the observed
data x, using the current estimate for Ψ. Let Ψ̂
(m)
be the value of Ψ after the mth
EM iteration. Then on the (m+1)th iteration, the E-step requires the computation
of the conditional expectation of lc(Ψ) given x, using Ψ̂
(m)




) = E{lc(Ψ)|x, Ψ̂
(m)}. (4.8)
In the expectation, we take Ψ = Ψ̂
(m)
. The expectation is with respect to the
unobserved zij .
As the complete-data log likelihood, lc(Ψ), is linear in the unobservable data
zij , the E-step (on the (m + 1)
th iteration) simply requires the calculation of the
current conditional expectation of Zij given the observed data x, where Zij is the
random variable corresponding to zij . Now
E(Zij |x, Ψ̂
(m)
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for i = 1, . . . , n; j = 1, . . . , g. According to (4.10), ẑij can take values between 0












ij {log πj + log f(xi;Φj)}. (4.11)
4.3.2 M-Step
The M-step on the (m+1)th iteration requires the global maximization of Q(Ψ; Ψ̂
(m)
)
with respect to Ψ over the parameter space ⊖ to give the updated estimate Ψ̂
(m+1)
.
That is, we seek the estimates of π’s and Φ’s using ẑ
(m)
ij in (4.11). One nice feature
of the EM algorithm is that for many common component densities fj, the solution
in the M-step often exists in closed form. Since the solution to the M-step depends
on the form of density chosen, we delay further details until the next section.
4.4 EM for the CMDA1 Model
The EM algorithm can be generalized to mixture discriminant analysis problems.
In this section, we derive the EM algorithm for the CMDA1 model using univariate
normal densities to construct the component densities, as in (4.4). The derivation
is similar to Section 4.3, but it will be more complicated because of the form of the
CMDA1 model.
Knowing that observation i is in the kth class, zi = (zi1k, . . . , ziPk)
T is a P -





1 if xi belongs to the j
th component of the kth class,
0 otherwise.
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Here
∑
j zijk = 1 for an observation i in a given class k. If yi = k, we assume
zijl = 0 for all l 6= k. The observations x = (xT1 , . . . ,xTn )T are called incomplete
data, while (xTi , z
T
i )
T with i = 1, . . . , n are called complete data (see Section 4.3).






where yi is the class label for observation i and f is defined in (4.3). As before,
we refer to the collection of all model parameters as Ψ. That is, in the CMDA1














where xij is the j
th element of the vector xi, xi = {xi1, . . . , xiP}. The notation
∑
i∈Ck
means summing over all observations belonging to the kth class.
In the derivations below and later in applications (Section 4.7.1), we assume
that the h(·) are univariate Gaussian densities. In the EM algorithm at iteration
a, we need to take the expectation of (4.13) given the observations and the current











zijk{log πjk + log N(xij ; µjk, σjk)
+
∑
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Here, ẑijk is the posterior probability that the i
th observation belongs to the jth












ijk{log πjk + log N(xij ; µjk, σjk)
+
∑
l 6=j N(xil; µl, σl)}. (4.16)
and the M-step seeks to maximize Q with respect to Ψ for fixed zijk. Differenti-
ating (4.16) with respect to the parameters, and equating these derivatives to zero





























































































Finally, by plugging in the parameter estimates, the estimates of posterior class
probabilities are (by Bayes’ theorem)




πjkN(xj ; µ̂jk, σ̂jk)
∏
l 6=j




P̂ (y = k|X = x) = 1. (4.23)
where τk is a prior probability for the class k.
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4.5 Application Issues of the EM Algorithm
In this section, we identify two technical problems with using the EM algorithm
to estimate the CMDA1 model. These problems will motivate the multi-step EM
algorithm proposed in Section 4.6.
4.5.1 Degeneracy
When applying the EM algorithm to the CMDA1 model, we notice that the EM
algorithm can converge to degenerate solutions. That is, the estimates of some
variances are zero or very close to zero. Usually this occurs because a mixture com-
ponent has only one observation associated with it. Figure 4.2 shows one example.
The data are plotted in (a). The highlighted green point in (b) is in a cluster with
only itself at the last iteration of the algorithm. As the EM algorithm proceeds,
σ̂12 → 0 and µ̂12 approaches the observed value of x for the highlighted point. As
σ̂12 → 0, the log likelihood goes to infinity. The reason for this problem is that the
MLE is not well defined in mixture models as the likelihood function of mixture
models is unbounded for any given sample size.
To see how such a degenerate solution can occur, consider a mixture of g uni-




















where Ψ = {π1, . . . , πg−1; µ1, . . . , µg; σ1, . . . , σg}, and φ(·) is a standard normal
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Figure 4.2: The EM algorithm converges to a degenerate solution. (a): the data
set; (b): one observation x∗ with the green triangle is the one that causes the
degenerate solution. (c): the parameter estimate of log(σ12) decreases to −∞; (d):
the corresponding log likelihood diverges toward infinity. The initial values of the
parameters in this example are selected by K-means. The log likelihood at iteration
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distribution. By letting µ1 = xi and σ1 → 0 with other parameters fixed, it is
easily seen that ln(Ψ)→∞.
The problem of degenerate solutions can occur quite often. For example, later
in Section 4.7.2, we show a simulated example in which 200 realizations of a data
set are generated, and EM leads to a degenerate solution every time.
4.5.2 Starting Values
In mixture modeling, it is well-known that the choice of good starting values for
parameters is very important in the EM algorithm (McLachlan & Krishnan 1997).
Good starting values can lead the EM algorithm to converge to good local optima.
Starting values can be chosen for either Ψ or zijk. In the thesis, the K-means
algorithm is used to choose starting values for the component labels, ẑ
(0)
ijk’s. As
different starting values can give very different results, we use multiple starting
values in our Multi-step EM algorithm. This will help the EM algorithm identify
good parameter estimates. A detailed discussion of the choice of starting values for
the Multi-step EM algorithm is given in Section 4.6, and assessment of estimate
quality is given in Section 4.7.
4.6 Multi-step EM Algorithm
We develop a special Multi-step EM algorithm, which is designed to improve the
chances of finding good local optima and avoiding degenerate estimates. The Multi-
step EM algorithm has three important features:
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(1) Multiple trials for K-means are used to identify good starting points.
(2) During an intermediate stage of the algorithm, variances are enlarged to pre-
vent degenerate solutions.
(3) The algorithm first optimizes the location parameters while holding the vari-
ance parameters fixed. Then the variances and location parameters are si-
multaneously optimized. Section 4.5 provides motivation for this by noting
that a poor µ estimate (e.g. µ = xi for some i) can lead to degeneracy in σ.
Because the Multi-step EM algorithm is sensitive to the starting points, (1) is
used to identify good starting values. Features (2) and (3) are combined to avoid
the degeneracy problem. The pseudo code of the Multi-step EM algorithm is listed
below:











• For t=1 to trial
(a) Run the K-means algorithm to obtain the cluster labels (1, . . . , P ) for each obser-
vation given class k;
(b) Match ẑ
(0)
























• Identify the estimates giving the best log.valuet, t∗ = arg maxt log.valuet as the initial
values for Step 2;
• Let σ̂2jk(0) ← σ̂2jk(0) × multiplier and σ̂2l (0) ← σ̂2l (0) × multiplier.





• Repeat, for m = 0, 1, 2...,
(a) Calculate ẑ
(m+1)


















l in (4.17), (4.18) and (4.20);
















If log.value(m+1) is infinite, stop, and return “The Algorithm Converged to A
Degenerate Solution”;
otherwise go to (a);










(0) is identified as the initial values
for Step 3.





• Repeat, for m = 0, 1, 2...,
(a) Calculate ẑ
(m+1)






































If log.value(m+1) is infinite, stop, and return “The Algorithm Converged to A
Degenerate Solution”;
otherwise go to (a);
Here, trial is a user-specified constant, which means how many sets of starting
values one wants to use. In the thesis, trial = 100 is employed. The initial values
of ẑ
(0)
ijk are either 0 or 1. Step 3 is the conventional EM algorithm. Thus the multi-
step EM can be considered as a sophisticated technique for finding good starting
values for the EM algorithm.
Before the beginning of Step 2, a tuning parameter multiplier is introduced to
adjust small estimates of variances, which usually result in singularity (degenerate
solutions). The label assignment of K-means is very sensitive to the outliers, each of
which can be a cluster with only a single point. The role of multiplier is to enlarge
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small variances and recruit more points for small clusters. In the thesis, multiplier
initially takes values of 2, 3, 4. For each multiplier, the three steps (Step 1 to
Step 3) in the Multi-step EM algorithm are run to identify the best parameter
estimates. If the algorithm could not converge to a local optima after running all
multiplier’s provided, then Step 2 is re-run with new multiplier value equal
to 1.5 × multiplierc, where multiplierc is the current one (in our experiment,
we begin with multiplierc = 4), then so on until the algorithm converges to a
local optimum. So a possible sequence of multiplier can be 2, 3, 4, 6, 9, 13.5, . . ..
The multipliers are no larger than 200. The algorithm will return a warning
“converged to a degenerate solution” if all multiplier’s fail to result in good
solutions.
Step 2 is designed to avoid degenerate solutions. Fixing the enlarged local and
global variances reduces the possibility that the algorithm moves towards a singular
solution too early and allows the algorithm to explore more parameter space before
converging to an estimate.
Why do we use K-means as a strategy to choose the starting values for the
multi-step EM algorithm? Initially, two kinds of strategies, hierarchical clustering
(Fraley & Raftery 2002) and K-means, were compared on the basis of their ability
to select better starting values. Using the starting values chosen by K-means,
the Multi-step EM algorithm always gave better performance on testing sets than
using starting values chosen by hierarchical clustering. In this experiment, the data
were simulated from the CMDA1 model, and “performance” was measured using
Average Hit Rate, a ranking measurement that will be discussed later in Section
Constrained Mixture Discriminant Analysis 73
4.8.1. Therefore, K-means is used as the strategy to choose starting values in the
thesis.
When applying the Multi-step EM algorithm to real data sets in drug discovery,
outliers can still cause difficulties with degenerate solutions. We adapt the Multi-
step EM algorithm so that in each iteration outliers are identified and removed.
For example, if an observation contributes large log likelihood (usually ∞), this
observation can be viewed as an outlier and removed from the data set. Here
the outliers are not due to any type of measurement errors, and they are just
compounds with very different structure from other compounds. Here, an outlier
is defined operationally, i.e. the algorithm behaviour determines what an outlier
is. They are likely to be far from other points, but they are defined in terms of
likelihood contributions and degeneracy. In the remaining of the thesis, all outliers
are defined the same way.
4.6.1 Illustrative Example
A two-dimensional data set simulated from the CMDA1 model is presented to help
us understand how the Multi-step EM algorithm proceeds from one step to the next
one and the influence of the initial values chosen by K-means. The data are plotted
in Figure 4.3. In this example, only one multiplier is used, i.e. multiplier = 2.
Choosing the initial values of ẑ
(0)
ijk, i.e. the probability that observation i be-
longs to the jth component of the kth class, is handled in Step 1 of the Multi-step
EM algorithm (Section 4.6). In Chapter 5, we prove that the CMDA1 model is
identifiable and does not have the label switching problem. The cluster labels of
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observations from K-means are considered as the initial values of zijk. Since label-
switching can occur with K-means, the cluster labels may not correspond to the
component labels of the CMDA1 model. In a regular mixture model, swapping
labels will not change the model, but it is not true for the CMDA1 model as cluster
j has cluster-specific parameters for xj .
We illustrate convergence of the multi-step EM algorithm in two scenarios,
corresponding to whether there is a good match between the initial values from
K-means and the final estimates. Figure 4.4 illustrates both good and bad matches
between the initial values from K-means. In the right side of Figure 4.4, it is clear
that the cluster labels in the real class are switched since the red “•” and “o”
plotting symbols are reversed from Figure 4.3.
A Run With “Good” Starting Values from K-means
The convergence of the parameters from the good starting values are plotted in
Figure 4.5 (a). The green symbols represent the estimates of µ’s (the class specific
and global means) and black symbols are the estimates of σ’s. The green symbols
at the right of the plot are the true means. The lines represent the true variances.
In Step 2, the Multi-step EM algorithm searches for optimal location parameters,
which do not change very much in Step 3. Then both the location and scale
parameters start converging to the true parameters in Step 3. The changes of the
log likelihood are plotted in Figure 4.5 (b). The comparisons between the true
cluster means and the estimates at various stages of the multi-step EM algorithm
are given in Table 4.1. In this case, both the K-means initial values of the µ’s and
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Figure 4.3: Illustrative example of the CMDA1 model in two dimensions. Class is
indicated by red/blue, and matching mixture components have the same plotting
symbol.
the 1-step EM values are close to the true values.
With “Bad” Starting Values from K-means
When the starting values are not that promising for the Multi-step EM algorithm,
it takes the algorithm a little bit longer to converge. The convergence performance
of the parameters from the “bad” starting values chosen by K-means is presented
in Figure 4.6 (a) and the log likelihood versus the iterations is plotted in Figure 4.6
(b). This example also shows that the Multi-step EM algorithm can automatically
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Figure 4.4: Matching of the initial values from K-means: left, a good match; right,
a bad match. Plotting symbols and colour are the same as in Figure 4.3.
















































Figure 4.5: when the starting values are “good”. (a): Convergence of the parameter
estimates; (b): Log likelihood versus iterations. Green symbols on the right of plot
(a) represent the means.
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Good Match Bad Match
True cluster Initial K-means Centre for Initial K-means Centre for
mean centre 1EM step centre 1EM step
Cluster 11 (Red •) (4.09, 9.67) (3.91, 9.66) (4.11, 9.64) (7.04, 9.35) (6.58,9.41)
Cluster 12 (Red ◦) (7.11, 9.06) (7.09, 9.08) (6.97, 9.12) (5.57, 9.68) (5.89,9.53)
Cluster 21 (Blue •) (-1.03, 9.67) (-1.04, 9.66) (-1.04, 9.64) (-1.04, 9.35) (-1.04,9.41)
Cluster 22 (Blue ◦) (7.11, 0.70) (7.09, 0.70) (6.97, 0.70) (5.57, 0.70) (5.89,0.70)
Table 4.1: The comparisions between the true cluster means and the centre esti-
mates for both good and bad matches.
adjust the “bad” starting values and converge to the optimal solutions. The “cross-
over” of the largest four means in Figure 4.6 (a) is an indication of a correction of
initially poor µ values. The comparisons between the true cluster means and the
estimates are given in Table 4.1. The x, coordinates of the initial K-means centres
are reversed between clusters 11 and 12. After 1 EM step, the estimates are already
beginning to move toward the correct values.
This example also illustrates an additional advantage of Step 2. By fixing scale
parameters, Step 2 focuses on adjusting location parameters in instances where the
initial match is poor.
4.6.2 Parallel Computation
Large drug data sets usually make computations very intensive. In the imple-
mentation of the two EM algorithms, parallel computing is employed to speed up
computations. A parallel computer is a kind of computer with multiple processors
acting to achieve some common goal. In this section, we discuss parallel computing
for the EM algorithm.
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Figure 4.6: when the starting values are “bad”. (a): Convergence of the parameter
estimates; (b): Log likelihood versus iterations. Green symbols on the right of plot
(a) represent the means.
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The first question for parallel computing is what can or can not be made parallel?
A fundamental issue is whether the code is dependent or not. For example the
assignments, a ⇐ b and a ⇐ c are not parallelizable since the value of a depends
on both b and c. However, a ⇐ b and c ⇐ d are parallelizable as two codes are
independent.
Figure 4.7 shows two kinds of parallel computing: (a) embarrassingly parallel
and (b) non-embarrassingly parallel. In “embarrassingly parallel” computing, each
iteration of code inside a loop is independent of other iterations. Many statistical
computations belong to this category, e.g. bootstrapping and cross-validation. In
Figure 4.7, the rectangular boxes represent a controlling processor (also called “mas-
ter”) and the circles represent slave processors or slaves. The controlling processor
sends jobs to each slave processor and collects results from each slave processor.
Figure 4.7: Parallel Computing: (a) embarrassingly parallel; (b) non-
embarrassingly parallel.
The EM algorithm is not an embarrassingly parallel algorithm since each itera-
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tion depends on the previous one as in Figure 4.7 (b). After timing each step in the
Multi-step EM algorithm, we find that E-step in the EM algorithm is computation-
ally intensive since this step involves calculation of the membership zijk for each
observation given class k. To determine membership, the normal density function
must be evaluated. This is an expensive operation due to calculation of a natural
exponent. Therefore, we decide to use the following parallel computing diagram
to speed up the process. Figure 4.8 illustrates how the parallel computing works
in the EM algorithm. The large data set has been split across each processor, e.g.
the first slave processor has observations from 1 to 100, the second slave processor
has observations from 101 to 200, etc. At the iteration m, the controlling processor
sends the current parameter estimates (µjk’s, µj’s, σjk’s, σj’s and πjk’s) to each
slave in order to calculate cluster labels for observations. Then the slave processors
send the values of ẑijk back to the controlling processor, which will conduct the
M-step of the EM algorithm, i.e. calculate the parameter estimates. The process
continues until some stopping rule is reached.
Therefore, for jobs that are not embarrassingly parallel, it is possible to do
parallelization by having processors communicate data. The speed-up from this
parallelization is less than linear, i.e., doubling the number of processors does not
make the algorithm run twice as fast. Usually speed-up is either the logarithm of
the number of processors or converges towards a value.
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Figure 4.8: Parallel computing for the EM algorithm. Usually, there are more
than four processors used in computations, and more than two sending-receiving
procedures.
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Factor Level 1 Level 2
1 Dimensionality 2 10
2 Covariance Structure same different
3 Sample Size small large
4 Proportion balanced unbalanced
5 Mean well separated not well separated
Table 4.2: 5 factors and their levels for the CMDA1 model. See text for precise
specifications of the levels used.
4.7 Performance of the Multi-step EM Algorithm
In this section, we compare the Multi-step EM algorithm to the EM algorithm
when both algorithms are used to estimate the parameters of the CMDA1 model.
Here and in the remainder of the thesis, we refer to these algorithms as “Multi-step
EM” and “EM”. All the simulated data sets used in the remainder of this chapter
are assumed to have two classes: active and inactive.
4.7.1 Design of the Simulation
All data will be simulated from CMDA1 models with a variety of parameter settings.
Five factors representing important properties of the CMDA1 model are carefully
chosen. Each of these factors has two levels. The factors and levels are summarized
in Table 4.2.
The interpretations of the five factors, their levels and how to simulate param-
eters are as follows:
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• Dimensionality: the number of descriptors in the data set. In the simulation,
either 2 or 10 dimensions are used. When dimensionality= 2, the model is a
simple model with only 14 parameters to be estimated. When dimensionality=
10, there are 78 parameters to be estimated. Here, we want to explore the
performance of Multi-step EM in two extreme situations.
• Covariance Structure: the within class covariance structures. The CMDA1
model is a mixture of multivariate normal densities with diagonal covariance
matrices. Each entry in the covariance matrices is a variance of a univariate
normal density function. The within class covariance structures for different
components can be the same or different. If Covariance Structure is the same
within classes, all the clusters share the same covariance, i.e. σ1 = σ11 = σ21,
σ2 = σ12 = σ22, and σ3 = σ13 = σ23 etc. This is the traditional con-
strained mixture model having a common diagonal covariance matrix. In
the simulation, we draw global parameters σj ∼ U(0.01, 1.5), j = 1, . . . , P .
When Covariance Structure is different both within and between classes, we
draw σj ∼ U(0.01, 1.5) and class specific variances σjk ∼ U(0.01, 1.5) for
j = 1, . . . , P and k = 1, . . . , K. Simulated data plotted in Figure 4.9 illus-
trates the two different levels of Covariance Structure while other factors are
the same.
• Sample Size: small (5×# of parameters) and large (10×# of parameters).
• Proportion: the proportions of active and inactive compounds in the data.
When Proportion is balanced, the active and inactive classes have the same
number of compounds. If Proportion is unbalanced, the total sample size is
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Figure 4.9: Covariance Structure: same (left) and different (right) while other
factors are fixed.
divided in a 1 : 9 ratio of active:inactive. The actual numbers of active and
inactive compounds in different cases are summarized in Table 4.3.
• Mean: the location parameters for each component. By carefully selecting
values for both local and global means, the clusters between classes can be
“Well Separated” or “Not Well Separated”. When Mean is well separated,
we draw µj1 ∼ U(−9,−3), µj2 ∼ U(−2, 4) and µj ∼ U(4, 10), j = 1, . . . , P .
When Mean is not well separated, we draw µjk ∼ U(−3, 3) and µj ∼ U(−3, 3),
j = 1, . . . , P and k = 1, . . . , K. Figure 4.10 shows two data sets: the left one
is well separated and the right one is not well separated.
We note that two of these factors (Covariance and Mean) involve simulations of
random values of the parameters of the CMDA1 model. The within-class mixture
weights (πjk’s) are set to be equal in all cases.
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Sample Size
Dimension Size Proportion Active Inactive Total
2 Small 1 : 1 35 35 70
2 Small 1 : 9 7 63 70
2 Large 1 : 1 70 70 140
2 Large 1 : 9 14 126 140
10 Small 1 : 1 195 195 390
10 Small 1 : 9 39 351 390
10 Large 1 : 1 390 390 780
10 Large 1 : 9 78 702 780
Table 4.3: The number of active and inactive compounds generated in the simula-
tion for all combinations of Dimension, Sample Size and Proportion.





















Figure 4.10: Clusters between two classes are Well Separated (left) or Not Well
Separated (right) while other factors are fixed.
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A full-factorial experiment in these five factors, each of which has two levels,
gives us a total of 32 combinations listed in Table 4.4.
In order to effectively compare Multi-step EM to EM, the total number of
starting sets for EM is taken as the product of the number of initial value sets
(trials) and the number of multiplier’s used in Multi-step EM. Therefore, the
total number of starting sets for EM varies, as the number of multiplier’s used in
the Multi-step EM may change in different simulations. By allowing EM and Multi-
step EM a comparable number of restarts, we hope that differences in performance
are mostly due to fixing σ’s and using multiplier’s in Step 2.
The experiment is carried out as follows:
• For each combination from 1 to 32 in Table 4.4, a model is simulated. These
models may share some parameters. For instance, combination 1 and 3 have
exactly the same numeric values of µ’s and σ’s.
• Holding the models fixed, 200 data sets are generated from each model ac-
cording to combinations 1 to 16. For combinations 17 to 32, 20 data sets
are simulated from each model to reduce the amount of computation. The
number of data sets is chosen to give small variation in average results, while
being computationally feasible.
We have in total 32 runs, and for each run, there are multiple replicates. We em-
phasize that a model is randomly sampled from each combination first, and then the
data sets are independently generated from each model. There is not considerable
variability in sampling a model due to our specified simulation procedure.
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Dimension Covariance Size Proportion Means
1 2 Same Small Balanced Well Separated
2 2 Same Small Balanced Not Well Separated
3 2 Same Small Unbalanced Well Separated
4 2 Same Small Unbalanced Not Well Separated
5 2 Same Large Balanced Well Separated
6 2 Same Large Balanced Not Well Separated
7 2 Same Large Unbalanced Well Separated
8 2 Same Large Unbalanced Not Well Separated
9 2 Different Small Balanced Well Separated
10 2 Different Small Balanced Not Well Separated
11 2 Different Small Unbalanced Well Separated
12 2 Different Small Unbalanced Not Well Separated
13 2 Different Large Balanced Well Separated
14 2 Different Large Balanced Not Well Separated
15 2 Different Large Unbalanced Well Separated
16 2 Different Large Unbalanced Not Well Separated
17 10 Same Small Balanced Well Separated
18 10 Same Small Balanced Not Well Separated
19 10 Same Small Unbalanced Well Separated
20 10 Same Small Unbalanced Not Well Separated
21 10 Same Large Balanced Well Separated
22 10 Same Large Balanced Not Well Separated
23 10 Same Large Unbalanced Well Separated
24 10 Same Large Unbalanced Not Well Separated
25 10 Different Small Balanced Well Separated
26 10 Different Small Balanced Not Well Separated
27 10 Different Small Unbalanced Well Separated
28 10 Different Small Unbalanced Not Well Separated
29 10 Different Large Balanced Well Separated
30 10 Different Large Balanced Not Well Separated
31 10 Different Large Unbalanced Well Separated
32 10 Different Large Unbalanced Not Well Separated
Table 4.4: The 32 combinations of the five factors with two levels.
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Run 1 2 3 4 5 6 7 8
Multi-step EM 0 0 0 20 0 0 0 1
EM 103 200 174 200 3 200 44 199
Run 9 10 11 12 13 14 15 16
Multi-step EM 0 1 0 14 0 0 0 1
EM 24 145 77 157 0 68 1 83
Table 4.5: Degenerate solutions from the Multi-step EM and EM algorithms. In
runs 17-32, all EM solutions are degenerate.
In the following sections, three comparisons between Multi-step EM and EM
will be made: degeneracy, parameter estimation and prediction accuracy via the
likelihood.
4.7.2 Degenerate Solutions
Compared to EM, one advantage of Multi-step EM is significantly reducing the
possibility that the algorithm converges to degenerate solutions. When the dimen-
sionality is 2, the hardest classification problem is probably the 12th combination,
i.e. the covariance structure is “Different”, the sample size is “Small”, the data are
“Unbalanced” and the clusters from different classes are “Not Well Separated”. For
combination 12, Multi-step EM converges 14 times to degenerate solutions, while
EM converges 157 times over 200 replicates. The number of degenerate solutions
for combinations 1-16 in Table 4.4 are summarized in Table 4.5.
From Table 4.5, although Multi-step EM sometimes still converges to degenerate
solutions, it has significantly reduced the amount of degenerate solutions. The
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Run 17 18 19 20 21 22 23 24
Multi-step EM 0 2 0 13 0 0 0 1
Run 25 26 27 28 29 30 31 32
Multi-step EM 0 1 0 16 0 1 0 1
Table 4.6: Degenerate solutions from the Multi-step EM for runs 17-32, while all
EM solutions are degenerate.
same experiments are also applied to high-dimensional cases (combinations 17 to
32). However, EM fails completely, always converging to degenerate solutions.
The degenerate solutions from the Multi-step EM algorithm for runs 17-32 are
summarized in Table 4.6. Thus, runs 17-32 will not be studied further in subsequent
comparisons.
4.7.3 Parameter Estimation Accuracy
We first consider the 200 replicates of model 12. Figure 4.11 displays histograms
of the four local standard deviation estimates σ̂jk, j = 1, 2, and k = 1, 2, obtained
via Multi-step EM and EM. Degenerate solutions are included in this plot, and
correspond to one or more σ̂jk being equal to zero. Figure 4.12 is similar but
for global σ̂j ’s, j = 1, 2. Figure 4.11 and Figure 4.12 indicate that Multi-step EM
gives more accurate parameter estimates than EM, since the estimates are generally
closer to the true values. The Multi-step EM estimates for both local and global
standard deviations have less variance than those estimated by EM. Moreover, for
most of the standard deviations, the estimates from EM are biased.
Mean square errors (MSE) for all the parameter estimates in combination 12
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Figure 4.11: The estimates of four local standard deviations (σ̂jk) estimated by
Multi-step EM (left column) and EM (right column) based on 200 realizations of
model 12. The vertical dotted lines indicate the true parameter values.
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Figure 4.12: The estimates of two global standard deviations (σ̂j) estimated by
Multi-step EM (left column) and EM (right column) based on 200 realizations of
model 12. The vertical dotted lines indicate the true parameter values.
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Table 4.7: The estimated MSEs for the parameters of combination 12, over 200
realizations. Degenerate solutions are included in these calculations.
are listed in Table 4.7.
The MSE’s for the estimates of σ11 of the first 16 low-dimensional cases are
plotted in Figure 4.13, which shows that Multi-step EM gives more accurate pa-
rameter estimates than EM overall. Plots for other 13 parameters (not shown here)
are similar.
4.7.4 Prediction Accuracy via Log Likelihood
We also compare the algorithms in terms of their prediction ability. Usually we
would like to know the performance of our model on some testing sets, as it is
a good measurement of how well a model predicts future data sets. Using the
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Multi−Step EM vs EM in MSE







Figure 4.13: The plot of MSE’s for the estimates of σ11 for combinations 1 to 16.
The x-axis and y-axis are in different scales. The line in the plot is the 45 degree
line, on which the MSE’s are equal.
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test set, we will evaluate ln(Ψ̂), the log likelihood of the parameter values, esti-
mated from the training set via EM or Multi-step EM. An additional advantage
of using the test set is that unless one observes a test point exactly equal to a
training point, ln(Ψ̂) will be less than ∞, enabling us to access the quality of
prediction for both degenerate and non-degenerate solutions. A large testing set
(100 ∗ sample size of the training data) is generated.
For combination 12 in Table 4.4, the differences of the log likelihood from the
log likelihood of the true parameters for the 200 testing sets are calculated using the
estimates from EM and Multi-step EM respectively. The testing size in this case is
7, 000. The differences are obtained by subtracting the true log likelihood from the
log likelihood estimated by each algorithm. The difference of the log likelihood is
denoted by
∆ = ln(Ψ̂)− ln(Ψ0). (4.24)
We expect ∆ < 0 since Ψ̂ maximizes the training likelihood, not the test likeli-
hood. The smaller the absolute difference is, the closer the estimated log likelihood
is to the truth. Figure 4.14 shows ∆ pairs corresponding to Multi-step EM and
EM. The absolute differences of log likelihood calculated by the Multi-step EM
algorithm are usually smaller than those calculated by the EM algorithm. In the
scatter plot of Figure 4.14, the line represents equal performance; points below the
line mean Multi-step EM is better than EM; those above the line mean Multi-step
EM is worse than EM. There are 150 points out of 200 under the line, i.e., Multi-
step EM has better prediction ability than EM. The frequency of such “wins” of
the Multi-step EM for combinations 1-16 are summarized in Table 4.8. For all 16
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low-dimensional combinations in Table 4.4, the same kind of pattern can be found
in the differences of the log likelihood compared between EM and Multi-step EM.




























Figure 4.14: A comparison log likelihood differences for EM and Multi-step EM
based on 200 testing sets generated from the model 12. The line is a 45 degree line.
The plot includes degenerate solutions.
4.7.5 Conclusions for the Multi-step EM Algorithm
From the above experiments, Multi-step EM has the following advantages compared
to EM:
• Multi-step EM can give accurate estimates for the parameters of the CMDA1
model.
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Combination 1 2 3 4 5 6 7 8
Wins 135 169 174 135 102 196 133 197
Combination 9 10 11 12 13 14 15 16
Wins 156 156 178 150 177 176 193 154
Table 4.8: Number of replicates (out of 200) in which Multi-step EM has test set
log likelihood that is superior to EM, for combinations 1-16.
• The estimates from Multi-step EM have lower MSE’s than those estimated
by EM.
• Multi-step EM is superior to EM in the prediction ability of the estimated
model.
• Multi-step EM significantly reduces the number of degenerate solutions.
Since Multi-step EM still cannot totally avoid degeneracy, another approach,
Penalized Maximum Likelihood Estimation (PMLE), is considered in the next chap-
ter.
4.8 Performance as Classifiers: CMDA1 vs. MclustDA
In this section, the CMDA1 model will be compared to the popular model-based
discriminant approach, MclustDA (Fraley & Raftery 2002). In MclustDA, the
density of x within each class is modeled as a mixture of multivariate normal
densities. In the form of MclustDA used here, we assume the multivariate normal
mixture components have diagonal covariance matrices, and allow both the mean
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vector and the covariance matrix to vary across mixture components. CMDA1 will
be estimated via the multi-step EM algorithm described in Section 4.6. Methods
will be compared on the basis of their predictive performance as classifiers.
Two scenarios are carefully considered to compare the CMDA1 model and the
MclustDA model: (1) the true model is the CMDA1 model (Section 4.8.2), and
(2) the true model is the MclustDA model (Section 4.8.3). For both scenarios,
the comparison between the CMDA1 model and the MclustDA model focuses on
prediction accuracy for testing sets. In order to compare the CMDA1 model and the
MclustDA model on a fair basis, the number of components in each model is made
the same as P (the dimensionality of the data). For example, if the dimensionality of
the data is 6, the number of components in both of the CMDA1 and the MclustDA
models is 6.
The next section introduces the Average Hit Rate (AHR), a performance crite-
rion for unbalanced data.
4.8.1 Comparison Criteria: Misclassification Rate and Av-
erage Hit Rate
Consider the common classification problem with 2 classes y ∈ {0, 1} (or the ac-
tive and inactive classes in drug discovery). Often, the misclassification rate and
log likelihood (or the equivalent measurement, deviance) are used as criteria for
model building (with training data) or for model assessment (with testing data).
The misclassification rate is simply the proportion of observations assigned to the
wrong classes. Since the misclassification rate is more straightforward than the log
Constrained Mixture Discriminant Analysis 98
likelihood, the misclassification rate is preferred here. Pursuing a low misclassifi-
cation rate is a common strategy for solving the classification problem. However,
the misclassification rate is not always an appropriate standard, especially in drug
discovery, where the active compounds are rare. When the proportion of active
compounds in the test data is small, even a “bad” classifier, which classifies all
active compounds in the testing set as inactive, still can return a small misclassifi-
cation rate. The reason is that the misclassification method is easily dominated by
the majority groups of data set. Hence the misclassification rate is not a reasonable
model assessing criterion for the rare target problems. We will use misclassification
rate, but only in the scenarios where response classes are balanced.
Wang (2005) developed the Average Hit Rate (AHR) as a criterion for drug
discovery problems. AHR measures the ability of classifiers to give the best ranking
of compounds. Suppose n compounds have been ranked according to some measure
of how likely a compound is to be active. Denote the response values for such an
ordered list of compounds by y(1), . . . , y(n), with y(1) corresponding to the compound
predicted to be the most likely to be active. y(i) equals 1 if the i
th compound is












i=1 y(i), i.e. the number of actives in the list. Table 4.9 is a simple
example to show how to calculate AHR. There are three different rankings. The
best ranking ranks all three active compounds before the two inactive ones, so the












= 1). The worst ranking
gives a higher ranking to the inactive compounds than the active ones, yielding
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1 1 1 1 1 0 0
2 1 1 1 1 0 0
3 1 1 0 0.67 1 0.33
4 0 0.75 1 0.75 1 0.5
5 0 0.6 0 0.6 1 0.6





Table 4.9: Example of calculating average hit rate.
AHR= 0.48. The middle ranking gives one of the active compounds lower priority
than one inactive compounds, and then has AHR equal to 0.92. Thus, AHR is a
good indicator of how well a classifier ranks active compounds.
In the following sections, misclassification rate is applied only when the sim-
ulated data sets are balanced, i.e. the active class has an equal amount of data
as the inactive class. The AHR will be used as a comparison criterion when the
simulated data sets are imbalanced. In Section 4.9, the AHR will be used in the
NCI Antiviral AIDS data, in which active compounds are only 2% of the whole
data set.
4.8.2 Data Simulated from CMDA1
Experimental Design
The 32 different CMDA1 models used in Section 4.7 are also used here to generate
data. For the combinations with balanced samples (runs 1, 2, 5, 6, 9, 10, 13, 14, 17,
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18, 21, 22, 25, 26, 29, 30), the misclassification rate is used to measure performance.
For the other 16 unbalanced combinations, AHR is the performance measurement.
Results
Table 4.10 summarizes the average misclassification rates and their standard errors
for Bayes’, the CMDA1 model and the MclustDA model. In the Bayes’ misclassifi-
cation rate, predictions are generated using the true values of all model parameters.
Table 4.11 summarizes the average AHR and their standard errors for Bayes’, the
CMDA1 model and the MclustDA model. In both tables, the average performance
measurement (misclassification rate or AHR) is calculated over 200 samples for
two-dimensional data, and 20 samples for 10-dimensional data. In all combina-
tions, CMDA1 is superior to MclustDA, with a lower misclassification rate (Table
4.10) and a higher AHR (Table 4.11).
A two-sample t-test for equal means is conducted to test if there is a significant
performance difference between CMDA1 and MclustDA for average misclassifica-
tion rate. In this test, unequal variances are assumed. For the average misclassi-
fication rate (see Table 4.12), there is a statistically significant difference between
CMDA1 and MclustDA at a 1% significance level, which indicates CMDA1 per-
forms significantly better than MclustDA in both low and high dimensional bal-
anced cases.
The same t-test with unequal variances assumed is also conducted for the aver-
age AHR’s (see Table 4.11, the unbalanced model) between CMDA1 and MclustDA.
The same conclusion can be made: CMDA1 has a significantly better performance
Constrained Mixture Discriminant Analysis 101
Bayes CMDA1 MclustDA
Combination Ave. Mis. Rate (se) Ave. Mis. Rate (se) Ave. Mis. Rate (se)
1 0.00 (0.00) 0.00 (0.00) 0.05 (0.00)
2 4.21 (0.02) 4.86 (0.09) 5.43 (0.08)
5 0.00 (0.00) 0.00 (0.00) 0.05 (0.00)
6 4.19 (0.01) 4.41 (0.02) 4.63 (0.01)
9 0.17 (0.00) 0.24 (0.00) 0.38 (0.00)
10 3.79 (0.02) 4.15 (0.00) 5.28 (0.07)
13 0.17 (0.00) 0.20 (0.00) 0.23 (0.01)
14 3.80 (0.01) 3.94 (0.02) 4.29 (0.04)
17 0.97 (0.00) 1.09 (0.00) 4.30 (0.00)
18 12.47 (0.00) 19.46 (0.14) 24.78 (0.15)
21 0.97 (0.01) 1.03 (0.01) 1.19 (0.02)
22 12.52 (0.03) 20.77 (0.18) 23.07 (0.09)
25 0.01 (0.00) 0.04 (0.00) 0.52 (0.00)
26 13.23 (0.00) 15.99 (0.06) 21.15 (0.18)
29 0.01 (0.00) 0.02 (0.00) 0.12 (0.00)
30 13.23 (0.02) 20.02 (1.27) 19.96 (0.27)
Table 4.10: Average Misclassification Rate (%) calculated for Bayes, CMDA and
MclustDA when the true model is the CMDA1 model. Standard errors are given
in parentheses.
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Bayes CMDA1 MclustDA
Combination Ave. AHR (se) Ave. AHR (se) Ave. AHR (se)
3 100 (0.00) 99.8 (0.12) 95.4 (0.68)
4 86.6 (0.08) 79.4 (0.54) 64.3 (0.09)
7 100 (0.00) 100 (0.00) 99.5 (0.00)
8 86.6 (0.05) 84.6 (0.16) 81.2 (0.28)
11 99.9 (0.00) 99.4 (0.20) 92.1 (0.85)
12 92.6 (0.04) 87.7 (0.48) 73.7 (1.14)
15 99.9 (0.00) 99.9 (0.00) 99.8 (0.01)
16 92.6 (0.03) 91.4 (0.17) 89.3 (0.21)
19 98.9 (0.01) 96.8 (0.43) 91.1 (0.12)
20 67.2 (0.04) 46.3 (1.32) 26.9 (0.87)
23 98.9 (0.00) 98.6 (0.05) 95.1 (0.11)
24 67.4 (0.02) 47.7 (1.09) 41.0 (0.90)
27 100 (0.00) 99.3 (0.35) 94.43 (0.08)
28 79.7 (0.02) 58.6 (0.32) 52.1 (0.68)
31 99.99 (0.00) 99.99 (0.00) 99.81 (0.04)
32 79.64 (0.01) 64.13 (0.24) 55.01 (0.39)
Table 4.11: Average AHR calculated (%) for Bayes, CMDA and MclustDA when
the true model is the CMDA1 model. Standard errors are given in parentheses.
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than MclustDA for unbalanced data.
4.8.3 Data Simulated from MclustDA
Experimental Design
When the true model is the MclustDA model, we perform a different experiment.
Five factors, each of which has two levels, are chosen to represent the properties
of the MclustDA model. The five factors and their levels are listed in Table 4.14.
Here, the MclustDA model shares some of the same assumptions as the CMDA1
model:
• The number of clusters in each class is the same as the dimensionality of the
data.
• The independence assumption of the descriptors still holds for the MclustDA
model, i.e. the within class covariance matrices are diagonal.
Most of the five factors and their levels are the same as in Section 4.7.1, except
Covariance Structure is constructed differently for MclustDA. Unlike CMDA, there
are no global parameters used in MclustDA. The interpretations for these factors
and their levels are:
• Dimensionality: the number of descriptors in the data set. There are two
choices for Dimensionality: either 2 and 10. As in the CMDA1 model, we
assume that the number of components in each class is equal to the dimen-
sionality. When the dimensionality is 2, there are two clusters in each class,
while for 10-dimensional data, there are 10 clusters in each class.
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t-test
Combination P-value Significance
1 < 2.2e-16 ***
2 2.070e-06 ***
5 < 2.2e-16 ***
6 8.66e-10 ***
9 1.683e-10 ***
10 < 2.2e-16 ***
13 8.258e-05 ***
14 1.321e-15 ***






29 < 2.2e-16 ***
30 0.001086 **
Table 4.12: Two sample t-test for CMDA and MclustDA when the true model is
the CMDA1 model. Differences in mean AHR significant at the 5%, 1%, and 0.1%
levels are denoted by *, **, and ***, respectively.




4 < 2.2e-16 ***
7 < 2.2e-16 ***
8 < 2.2e-16 ***
11 8.096e-15 ***











Table 4.13: Two sample t-test for CMDA1 and MclustDA when the true model is
the CMDA1 model. Differences in mean AHR significant at the 5%, 1%, and 0.1%
levels are denoted by *, **, and ***, respectively.
Factor Level 1 Level 2
1 Dimensionality 2 10
2 Covariance Structure same different
3 Sample Size small large
4 Proportion balanced unbalanced
5 Mean well separated not well separated
Table 4.14: Five factors and their levels for the MclustDA model.
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• Covariance Structure: the within and between class covariance structures. Un-
der our independence assumption, the covariance matrices are diagonal. Two
extreme situations are considered here: the covariance matrices are either
the same or different within and between classes. If Covariance Structures
are the same within and between classes (i.e. Σjk = Σ, for j = 1, . . . , P
and k = 1, . . . , K), a vector with a length being equal to the dimensionality
is randomly sampled from a uniform distribution U(0.01, 2), and then the
values of the vector are assigned to the diagonal values of the covariance ma-
trix Σ. When Covariance Structures are different, the diagonal vectors of all
covariance matrices will be independently and randomly sampled from the
same uniform distribution U(0.01, 2). Figure 4.15 illustrates these different
scenarios.

























Figure 4.15: Variance Structure: (a) same or (b) different while other factors are
the same.
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• Sample Size: small (5×# of parameters) and large (10×# of parameters).
• When Proportion is balanced, the active and inactive classes have the same
number of compounds. If Proportion is unbalanced, the active class has only
1/10 of the whole data set. The actual numbers of active and inactive com-
pounds in different cases are summarized in Table 4.15.
• Mean: the mean vector for each cluster. By carefully selecting values of mean
vectors, the classes can be either “Well Separated” or “Not Well Separated”.
When Mean is well separated, the elements of mean vectors for the active
class will be independently sampled from U(−9,−3) and those for the inac-
tive class will be independently sampled from U(−3, 3). When Mean is not
well separated, all the means are randomly and independently sampled from
U(−3, 3). Figure 4.16 shows two data sets: (a) is well separated and (b) is
not well separated.
Results
Here, only the average performance measurements (misclassification rate or AHR)
and their standard errors, and hypothesis tests of equal average performance are
listed. Both Table 4.16 and Table 4.17 indicate that in the low-dimensional cases
(combinations 1-16), MclustDA outperforms CMDA1. In most of the high-dimensional
cases, the CMDA1 model is surprisingly superior to the MclustDA model, return-
ing smaller misclassification rates and higher AHR’s. We hypothesize that in these
cases, MclustDA performs poorly because of the large number of parameters (rel-
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Sample Size
Dimension Size Proportion Active Inactive Total
2 Small 1 : 1 45 45 90
2 Small 1 : 9 9 81 90
2 Large 1 : 1 90 90 180
2 Large 1 : 9 18 162 180
10 Small 1 : 1 1045 1045 2090
10 Small 1 : 9 209 1881 2090
10 Large 1 : 1 2090 2090 4180
10 Large 1 : 9 418 3762 4180
Table 4.15: The number of active and inactive compounds generated in the simu-
lation for all combinations of Dimension, Sample Size and Proportion.




















Figure 4.16: Clusters between two classes are: (a) Well Separated or (b) Not Well
Separated while other factors are same.
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CMDA1 MclustDA Difference t-test
Comb. Ave. Mis. Rate (se) Ave. Mis. Rate (se) CMDA1 vs MclustDA P-value Significance
1 0.02 (0.00) 0.00 (0.00) 0.02 0.003555 **
2 18.47 (0.02) 12.88 (0.02) 5.59 < 2.2e-16 ***
5 0.00 (0.00) 0.00 (0.00) 0.00 0.003130 **
6 18.32 (0.01) 12.77 (0.01) 5.55 < 2.2e-16 ***
9 0.07 (0.00) 0.00 (0.00) 0.07 6.1e-07 ***
10 17.99 (0.03) 16.19 (0.03) 1.80 4.683e-15 ***
13 0.05 (0.00) 0.00 (0.00) 0.05 3.355e-09 ***
14 17.75 (0.02) 15.85 (0.02) 1.90 < 2.2e-16 ***
17 0.00 (0.02) 0.00 (0.00) 0.00 0.0002437 ***
18 25.23 (0.25) 41.11 (0.01) -15.88 8.21e-15 ***
21 0.11 (0.02) 0.00 (0.00) 0.11 3.054e-05 ***
22 25.17 (0.20) 41.04 (0.87) -15.87 3.397e-14 ***
25 0.34 (0.01) 0.44 (0.13) -0.10 0.4304
26 25.80 (0.26) 50.29 (0.86) -24.49 < 2.2e-16 ***
29 0.34 (0.00) 0.62 (0.13) -0.28 0.04395 *
30 25.86 (0.12) 49.76 (0.86) -23.9 < 2.2e-16 ***
Table 4.16: Mean misclassification rate for CMDA1 and MclustDA when the true
model is the MclustDA model. Differences in mean misclassification rate significant
at the 5%, 1%, and 0.1% levels are denoted by *, **, and ***, respectively.
ative to available data). For example, with 10 dimensions, the CMDA1 model has
78 parameters, while MclustDA model would have 418 parameters.
In such situations, CMDA1 makes more parsimonious use of data and seems to
offer superior performance as a result.
Constrained Mixture Discriminant Analysis 110
CMDA1 MclustDA Difference t-test
Comb. Ave. AHR (%) (se %) Ave. AHR (%) (se %) CMDA1 vs MclustDA P-value Significance
3 100 (0.00) 100 (0.00) 0.00 0.99
4 70.80 (0.19) 80.40 (0.10) -9.60 5.693e-15 ***
7 100 (0.00) 100 (0.00) 0.00 0.99
8 71.66 (0.09) 81.29 (0.05) -9.63 < 2.2e-16 ***
11 100 (0.00) 99.99 (0.00) 0.01 0.442
12 53.61 (0.25) 62.57 (0.25) -8.96 1.469e-09 ***
15 100 (0.00) 100 (0.00) 0.00 0.8467
16 54.08 (0.28) 66.71 (0.10) -12.63 1.166e-12 ***
19 100 (0.00) 100 (0.00) 0.00 0.99
20 53.82 (1.29) 14.98 (0.49) 38.84 < 2.2e-16 ***
23 100 (0.00) 100 (0.00) 0.00 0.03097 *
24 53.82 (1.30) 15.54 (0.84) 38.28 < 2.2e-16 ***
27 99.99 (0.00) 99.22 (0.21) 0.77 0.001590 **
28 31.52 (1.08) 10.59 (0.29) 20.93 8.06e-15 ***
31 99.99 (0.00) 98.92 (2.67) 1.07 0006772 ***
32 31.91 (1.21) 9.58 (1.91) 22.33 7e-14 ***
Table 4.17: Average AHR (%) calculated for CMDA and MclustDA when the true
model is the MclustDA model. Two sample t-test of mean misclassification rate for
CMDA1 and MclustDA when the true model is the MclustDA model. Differences
in mean AHR significant at the 5%, 1%, and 0.1% levels are denoted by *, **, and
***, respectively.







Table 4.18: NCI data: AHR (%) calculated for CMDA and MclustDA.
4.9 Application to the NCI Antiviral AIDS Data
We apply both the CMDA1 model and the MclustDA model to the NCI Antiviral
AIDS Data. The data set is randomly split using stratified sampling into a training
set and a test set, each with n = 14, 906 compounds, of which 304 are active
compounds. We conduct four experiments (4 splits), which will be referred to as
“Split 1”, . . ., “Split 4” in the text below. Performance is assessed by the AHR on
the test set. The AHR’s returned from both approaches for the 4 splits are listed
in Table 4.18. It is clear that the CMDA1 model returns higher AHR’s than the
MclustDA model. Over the four replications, a paired t-test concludes that the
CMDA1 model significantly outperforms MclustDA at a 5% significance level.
We also plot the densities of each BCUT descriptor for the active class and the
inactive class in Figure 4.17. It clearly indicates that the estimated means match
the centres of the densities.
The mixing proportions estimated from Split 2 are: the active class (π11, π21,
π31, π41, π51, π61) = (0.16, 0.37, 0.05, 0.17, 0.14, 0.12) and the inactive class (π12,
π22, π32, π42, π52, π62) = (0.03, 0.09, 0.23, 0.21, 0.23, 0.21). The values of these





























































































































































































Figure 4.17: The plot of densities of the BCUT descriptors for the active class (the
first row) and the inactive class (the second row). The vertical line in each density
plot is the estimated local mean from Split 2.
estimates indicate how important each BCUT is in the active and inactive classes.
The larger values mean the corresponding BCUT descriptors are important for the
discriminant analysis. For instance, using 0.15 as a threshold, BCUT3, BCUT4,
BCUT5, and BCUT6 in the inactive class may distinguish inactive clusters from
active clusters along the four descriptor dimensions. Wang (2005, Chapter 6) found
that BCUT4 and BCUT6 are important variables. She used a subset K-nearest
neighbour technique to identify the important variables.
Selecting important variables is an important topic. Since our focus here is to
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explore multiple-mechanisms of drug data sets and subsets of descriptors, selecting
important variables has not been carefully and systematically studied. In the future,
we will focus on how to select important variables.
4.10 The CMDA Second Order Model (CMDA2)
We also consider the CMDA Second Order model (CMDA2), which is based on
two-dimensional subspaces of descriptors. In the CMDA2 model, two variables can
be simultaneously discriminate between classes. That is, activity is determined
by interactions between two predictors. The CMDA2 model provides flexibility to
identify this type of pattern. In this section, we will only present the EM derivations
for the CMDA2 models, and one simulation example. The CMDA2 model will be
applied to the NCI data later in Section 5.6.
This model explores the two-dimensional subsets of descriptors. For P descrip-
tors, there are P (P −1)/2 components in each class, as each component is specified
by a pair of descriptors. The second order model in the normal case can be written
as







N(xl; µl, σl), (4.26)
where Ψk represents local parameter for class k and ΨG is global parameter.
A difference from the notation used in the CMDA1 model is that here j in-
dexes a pair of descriptors, i.e. j = {1, 2, . . . , P (P − 1)/2} corresponds to pairs
{(1, 2), (1, 3), . . . , (P − 1, P )}. We also note that the global terms (N(xl; µl, σl) in
(4.26)) remain univariate for reasons of parsimony.
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As before, the zijk’s represent the memberships of observations. The complete-










zijk[log πjk + log MV N(xj; µjk,Σjk) + (4.27)
∑
l 6=j
log N(xl; µl, σl)],
where,






(xj − µjk)TΣ−1jk (xj − µjk)
and
log N(xl; µl, σl) = −
1
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l 6=j N(xl; µl, σl)
∑p(p−1)/2
j∗=1 π̂j∗kMV N(xj∗ ; µj∗k,Σj∗k)
∏
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4.10.1 A Simulation Study
The simulation for the CMDA2 model is as follows:
• The simplest CMDA2 model is considered, P = 3, which means the data are
3-dimensional, and the CMDA2 model has 3 components. For class k, the
3-dimensional CMDA2 model in normal densities is written as
f(x;Ψk, ΨG|y = k) = π1kMV N((x1, x2); µ1k,Σ1k)N(x3; µ3, σ3)
+π2kMV N((x1, x3); µ2k,Σ2k)N(x2; µ2, σ2)
+π3kMV N((x2, x3); µ3k,Σ3k)N(x1; µ1, σ1). (4.34)
• Each element of the class specific means, µjk’s, is independently sampled
from U(−10, 10).
• Global means are independently sampled from U(−10, 10).
• Class specific covariance matrices, Σjk’s, are assumed to have equal off-
diagonal covariance (e.g. σx1x2) that is 0.5. Diagonal entries (e.g. σ
2
x1
and σ2x2) for each class specific covariance matrix are independently sam-
pled from U(0.01, 2). These diagonal and off-diagonal entries have to satisfy
0.5 = σx1x2 ≤ σx1σx2 , since |cov(X1, X2)| ≤ σX1σX2 . Simulated parameter
values that do not satisfy this constraint are discarded.
• The global variances are independently sampled from U(0.01, 2).
• The training sample size is 360, while the testing size is 3600.
• The active:inactive balance is 1 : 9.





Table 4.19: Average AHR (%) and standard errors (%) calculated for Bayes,
CMDA2 and MclustDA for the simulated data.
• Holding the parameters sampled fixed, 200 runs are implemented to get the
average of parameter estimates and standard errors.
Since the data are unbalanced, AHR is used as comparison measurement be-
tween the CMDA2 model and the MclustDA model when the data are simulated
from the CMDA2 model. The average parameter estimates and corresponding stan-
dard errors over 200 runs are summarized in Table 4.19. A hypothesis test indicates
that CMDA2 has a significantly higher AHR than MclustDA.
Our simulation results show the CMDA2 model performs better than the MclustDA
model, but further research needs to be done in order to explore the properties of
the CMDA2 model.
We also apply the CMDA2 model to the NCI Antiviral AIDS data. First,
however, the algorithm always converges to the degenerate solutions for the un-
constrained CMDA2 model and secondly, it is very difficult to identify good local
maxima even after the degenerate solutions are removed for a type of CMDA2
model with diagonal covariance matrices. Hence, a penalized CMDA2 model will
be discussed in Section 5.6.
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4.11 Discussion and Conclusion
In this chapter, a new mixture discriminant analysis model (CMDA) is introduced
and discussed. The primary goal in drug discovery is to identify active compounds.
However, the rareness of active compounds makes this difficult. A method like
LDA, which assumes equal covariance matrices within each class is not very flexible.
Approaches like QDA and MclustDA that assume different covariance matrices for
different classes could suffer from the poor estimates of parameters for the active
class due to the fewer active compounds in the data. The CMDA model is more
flexible than LDA as different covariance matrices are assumed in each class, and
more parsimonious than QDA and MclustDA as covariance matrices share some
global parameters.
Comparisons between the CMDA first order model and the MclustDA model are
conducted in two carefully designed scenarios: the true model is the CMDA1 model
and the true model is the MclustDA model. The CMDA1 model outperforms the
MclustDA model when the simulated data is generated from the CMDA1 model.
When the true model is the MclustDA model, the MclustDA model is superior in
low-dimensional cases and the CMDA1 model is superior in the high-dimensional
cases, especially when the data are imbalanced.
In order to handle the degeneracy problem arising from estimating the param-
eters for the CMDA1 model, the Multi-step EM algorithm is designed to avoid
degenerate solutions and converge to the best local optima. Compared to the EM
algorithm, the Multi-step EM algorithm has significantly reduced the number of
degenerate solutions. Since the Multi-step EM algorithm can not totally avoid
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the degenerate solutions, however, a penalized and model-based approach will be
discussed in the next chapter.
Chapter 5
Penalized Maximum Likelihood
Estimation for the CMDA1 and
CMDA2 models
In this chapter, we seek to use penalization as a way of avoiding degenerate so-
lutions. Section 5.1 gives the notation used in this Chapter. The definition and
proof of identifiability for the CMDA1 model is given in Section 5.2. The proof
of asymptotic consistency of the penalized maximum likelihood estimate (PMLE)
for the CMDA1 model is presented in Section 5.3. A simulation study using two
penalty functions is given in Section 5.4 and the application of the PMLE on a drug
data set is shown in Section 5.5. The PMLE approach is extended to the CMDA2
model in Section 5.6, and illustrated on the NCI data. Finally, conclusions are
made in Section 5.7.
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5.1 Introduction
Before discussing penalized estimation, let us recall the CMDA1 model and some
notation used in Chapter 4. In general, the CMDA1 model specifies the density of
feature vector x given class k as:








where Ψk = (π1k, . . . , π(p−1)k, Φ̄1k, . . . , Φ̄Pk)
T is the vector containing all the un-
known parameters specified in this mixture model for class k. Denote the global
parameters ΨG = (Φ̄1, . . . , Φ̄P )
T . The full set of parameters for all K classes is
Ψ = (Ψ1, . . . ,ΨK,ΨG)
T . As in Chapter 4, we assume h(·) is a univariate normal
density.
Some notation used in the model is as follows:
• The observations are represented by (xi, yi), i = 1, . . . , n, where xi ∈ ℜP and
yi is a categorical variable with values 1, . . . , K. K is the total number of
classes.
• k = 1, . . . , K indexes the K classes.
• j = 1, . . . , P indexes the P components in each class.
5.2 Identifiability
The estimation of Ψ on the basis of the observations (xi, yi) is only meaningful if
Ψ is identifiable. In general, a parametric family of densities f(x;Ψ) is identifiable
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if distinct values of the parameter Ψ determine distinct members of the family of
densities f(x;Ψ) : Ψ ∈ Ω, where Ω is the specified parameter space; that is
f(x;Ψ) = f(x;Ψ∗), (5.2)
if and only if
Ψ = Ψ∗.
However, for mixture models, the above definition of identifiability of Ψ is not
suitable. For instance, suppose f(x;Ψ) has two component densities, f(x;Φa) and
f(x;Φb), that belong to the same parametric family. Then (5.2) will still hold
when the component label a and b and corresponding mixture weights πa and πb
are interchanged in Ψ. That is, Ψ is not identifiable. Indeed, if all the g component
densities belong to the same parametric family, then f(x;Ψ) is invariant under the
















be any two members of a parametric family of mixture models. This parametric
family is said to be identifiable for Ψ ∈ Ω if
f(x;Ψ) ≡ f(x;Ψ∗)
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if and only if g = g∗ and the component labels are permuted so that
πj = π
∗
j and f(x;Φj) = f(x;Φ
∗
j) (j = 1, . . . , g). (5.3)
So, there are two distinct definitions of identifiability: the identifiability of Ψ
and the identifiability of a parametric family. For the CMDA1 model, the inter-
changing of component labels will result in a different parametric density, so Ψ is
identifiable in this model. Therefore, the identifiability of the CMDA1 model as a
parametric family is our focus.
Identifiability for the CMDA1 model with K classes is defined in a slightly
different way as we need to show that K conditional mixture distributions are
jointly identifiable:
f(x;Ψ1|y = 1) ≡ f(x;Ψ∗1|y = 1),
f(x;Ψ2|y = 2) ≡ f(x;Ψ∗2|y = 2), (5.4)
. . .
f(x;ΨK|y = K) ≡ f(x;Ψ∗K|y = K).










For the case of univariate mixtures, we first construct a family of 1-dimensional
component densities from which univariate mixtures are to be formed, i.e.
F = {f(x;Φ);Φ ∈ Rm, x ∈ R}, (5.5)
where f(x;Φ) is a component density. Then the class of finite mixtures of F with
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the appropriate class of density functions, H, is defined by








cj = 1, f(x;Φj) ∈ F , k = 1, 2, . . .}
Before proving the identifiability of the CMDA1 model with 2 classes, we list
several theoretical results necessary for the proof.
Theorem 1 (Yakowitz & Spragins (1968)) A necessary and sufficient condi-
tion that the class H of all finite mixtures of the family F of (5.5) be identifiable is
that F be a linearly independent set over the field of real numbers R.
Corollary 1 (Yakowitz & Spragins (1968)) A necessary and sufficient condi-
tion that the class H of all finite mixtures of the family F of (5.5) be identifiable is
that the image of F under any vector isomorphism on < F > (the span of F) be
linearly independent in the image space.
Corollary 2 (Teicher (1963)) The class of all finite mixtures of univariate nor-
mal distributions are identifiable.
Proof: Let (µ, σ2) denote the mean and variance of a typical member of F , and
φ(z; µ, σ) = exp(µz + 1
2
σ2z2) be the moment-generating functions of members of F .








2) ≡ 0, (5.7)
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must give cj = 0, j = 1, 2, . . . , k.
First, we order σ2j , j = 1, . . . , k, and choose the largest one, say, σ
2
j∗. The























Hence cj∗ = 0 and we remove this term from the left side of equation (5.7).
If the largest σ is not unique, e.g. σj1 = σj2, then we compare µj1 and µj2. If
µj2 < µj1, the same technique as above will be used to get cj1 = 0. If µj1 = µj2, these
two terms can be combined, and then we repeat a similar procedure: compare σ’s,
compare µ’s, prove cj = 0 for some j and remove the terms with zero coefficient
from (5.7).
Therefore, we prove that the class of all finite mixtures of univariate normal
distributions are identifiable as all the coefficients cj of equation (5.7) are 0.
The above proof is slightly different from the original proof given in Teicher
(1963) as we use the moment generating function, which provides a more direct
proof.
We now use two methods to prove the identifiability of CMDA1 model: the
first proves the theorem in terms of the product of univariate normal distributions
and the second uses multivariate normal distributions. The second proof is on the
basis that the CMDA1 model can be viewed as a mixture of multivariate normal
distributions with diagonal covariance matrices.
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Theorem 2 (Identifiability of the CMDA1 model) The CMDA1 model is iden-
tifiable under the assumption that the descriptors (i.e. the x’s) are independent
within component densities.
Proof: This proof is similar to the proof of Corollary 2.
First, we define the sets F and H for the CMDA1 model in class k.
F = {f(x;Ψ) = N(xj ; µjk, σjk)
∏
l 6=j
N(xl; µl, σl)}, (5.8)




cjN(xj ; µjk, σjk)
∏
l 6=j




cj = 1, J = 1, 2, . . .} (5.9)
Let φ(z;Ψ) be the moment-generating function of f(x;Ψ), then































l )} ≡ 0 (5.11)
must give c1 = c2 = . . . = cJ = 0.
The same technique as in Corollary 2 is employed here to prove all the coef-
ficients are zero in equation (5.11). Find the largest σ2∗, and divide both sides of
equation (5.11) by the term with the largest σ2∗. Then the coefficient of that term
is zero. If the largest σ2∗ is not unique, the other σ
2’s in the terms with the largest
σ2∗ will be compared. If the σ
2’s are also the same, then identify the largest of the
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corresponding µ∗’s. If the µ∗’s compared are equal, they can be combined. The same
process is repeated until all terms of (5.11) are eliminated.
Therefore, we prove that the CMDA1 model is identifiable as all the coefficients
of equation (5.11) are zero.
5.3 Asymptotic Consistency of the PMLE for the
CMDA1 Model
As discussed in Section 4.5, the likelihood function of mixture models is unbounded
for any given sample size. Hence, the ordinary maximum likelihood estimators
(MLE) of mixture models are not consistent. This suggests that MLE’s of the
CMDA1 model are not consistent either.
In order to solve this problem, researchers commonly consider estimates on con-
strained parameter spaces. For example, Redner (1981) proved that the maximum
likelihood estimate of Ψ exists and is globally consistent in every compact sub-
parameter space containing the true parameter Ψ0. Hathaway (1985) proposed to
estimate Ψ by maximizing the likelihood function with a restricted parameter space
defined by the following constraint:




≥ c > 0}
for some constant c. Hathaway’s constrained MLE
Ψ̂n = arg max
Ψ∈⊖c
ln(Ψ)
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is shown to be strongly consistent provided that the true mixing distribution Ψ0
belongs to ⊖c. Despite the elegant results of Redner (1981) and Hathaway (1985),
these methods all suffer, at least theoretically, from the risk that the true mixing
distribution Ψ0 may not satisfy the constraint imposed (Chen, Tan & Zhang 2007).
Chen et al. (2007) suggested that the approach of adding a penalty term to the
ordinary log-likelihood function can avoid the above concern. They defined the
penalized log likelihood as
P ln(Ψ) = ln(Ψ) + pn(Ψ) (5.12)
so that pn(Ψ) → −∞ as min{σj : j = 1, . . . , p} → 0. Then the estimate of Ψ is
the penalized maximum likelihood estimator (PMLE)
Ψ̃n = arg max
Ψ
P ln(Ψ). (5.13)
In this section, we introduce a family of simple penalty functions on the vari-
ances (especially class-specific variances) in the CMDA1 model. We will prove that
the PMLE of the two-dimensional CMDA1 model is asymptotically consistent. The
proof in Section 5.3.3 is based on Chen et al. (2007), which proved asymptotic con-
sistency for penalized univariate normal mixtures. The proofs in this chapter are for
two-dimensional multivariate normal mixtures with diagonal covariance matrices.
In the following sections, we first borrow two technical lemmas from Chen et al.
(2007) to assess the number of observations falling in a small neighborhood of the
location parameters. Then we prove the asymptotic consistency of Ψ̃n for general
two-dimensional multivariate normal mixtures with diagonal covariance matrices.
Since the two-dimensional CMDA1 model is a special case of a two-dimensional
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multivariate normal mixture with diagonal covariance matrices, it is easy to con-
clude that the two-dimensional CMDA1 model is also asymptotically consistent.
5.3.1 Technical Lemmas
Two lemmas are borrowed from Chen et al. (2007) to prove the asymptotic con-
sistency of the PMLE of the CMDA1 model. Please note that these lemmas are
used for one dimension, i.e. P = 1 and a single group of mixtures (i.e. there are no
classes). Thus the data are x1, . . . , xn. We first give some definitions and quantities.






where the mixing distribution is Ψ = (π1, . . . , πP−1;Φ1, . . . ,ΦP ).
The basic idea of PMLE is to counter the effect of observations close to those
location parameters with small scale parameters. For this purpose, assessing the
number of observations falling in a small neighborhood of the location parameters







I(0 < xi − µ < −σ log σ) (5.15)
which is the supremum (or least upper bound) of the number of observations falling
into the positive side of a small neighborhood of all possible µ’s. We are only
interested in Ωn(σ) when σ is very small, so we can assume −σ log(σ) > 0. The
number of observations falling into the negative side of µ can be assessed in a similar
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way. Let Fn(x) = n
−1
∑n
i=1 I(xi ≤ x) be the empirical distribution function. Then
we have
Ωn(σ) = n sup
µ
[Fn(µ− σ log σ)− Fn(µ)].
Let F = E(Fn) be the true cumulative distribution function.
We now define two quantities
T = max{sup
x
f(x;Ψ0), 8}, and δn(σ) = −Tσ log(σ) + n−1,
where Ψ0 is the true mixing distribution. T is either the highest point in the true
density or the constant 8, which is chosen for the convenience of the proof.
The following lemma uses Bahadur’s representation to give an order assessment
of n−1Ω(σ).
Lemma 5.3.1 (Chen et al. (2007)) Under the finite normal mixture model as-
sumption, as n→∞ and almost surely, we have:
1. For each given σ between 8
nT
and exp(−2). We have
sup
µ
[Fn(µ− σ log σ)− Fn(µ)] ≤ 2δn(σ); (5.16)





[Fn(µ− σ log σ)− Fn(µ)] ≤ 2(log n)2/n. (5.17)
Chen et al. (2007) use the same proof as below. We reproduce this proof here
since a similar strategy will later be used in Section 5.3.3.
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Proof:
1. Let η0, η1, . . . , ηn be some real numbers such that




[Fn(µ− σ log σ)− Fn(µ)]
≤ max
j
[Fn(ηj − σ log σ)− Fn(ηj−1)]
≤ max
j
[{Fn(ηj − σ log σ)− Fn(ηj−1)} − {F (ηj − σ log σ)− F (ηj−1)}]
+ max
j
[F (ηj − σ log σ)− F (ηj−1)]. (5.18)
By the mean value theorem and for some ηj ≤ ξj ≤ ηj − σ log σ, we have
F (ηj − σ log σ)− F (ηj−1) = F (ηj − σ log σ)− F (ηj) + n−1
= f(ξj;Ψ0)|σ log σ|+ n−1
≤ T |σ log σ|+ n−1 = δn(σ). (5.19)
Then, we have maxj [F (ηj − σ log σ)− F (ηj−1)] ≤ δn(σ). Further, for j = 1, . . . , n,
define
∆nj = |{Fn(ηj − σ log σ)− Fn(ηj−1)} − {F (ηj − σ log σ)− F (ηj−1)}|.
By the Bernstein inequality (Serfling, 1980), for any t > 0, we have







Since |σ log σ| is monotone in σ, for exp(−2) > σ > 8/(nT ),










≥ 8 log n
nT
.
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By letting t = δn(σ) in (5.20), we obtain








Thus for any σ in this range,
P{max
j




P{∆nj ≥ δn(σ)} ≤ 2n−2. (5.22)
Linking the above inequality back to supµ[Fn(µ− σ log σ)− Fn(µ)] (5.18), we get
P{sup
µ
[Fn(µ− σ log σ)− Fn(µ)] ≥ 2δn(σ)} ≤ P{max
j
∆nj ≥ δn(σ)} ≤ 2n−2.(5.23)
Then according to the Borel-Cantelli Lemma, supµ[Fn(µ−σ log σ)−Fn(µ)] ≥ 2δn(σ)
infinitely does not exist. So
sup
µ
[Fn(µ− σ log σ)− Fn(µ)] ≤ 2δn(σ). (5.24)
Hence we have proven the first part of the Lemma.
2. When 0 < σ < 8
nT
, by using the Bernstein inequality again, we have







Let t = n−1(log σ)2
P{∆nj ≥ n−1(log σ)2} ≤ 2 exp{−(log σ)2} ≤ n−3.
Thus for any σ in this range,
P{max
j




P{∆nj ≥ n−1(log σ)2} ≤ n−2, (5.25)




[Fn(µ− σ log σ)− Fn(µ)] ≥ 2n−1(log σ)2} ≤ (5.26)
P{max
j
∆nj ≥ n−1(log σ)2} ≤ 2n−2.
Then according to the Borel-Cantelli Lemma, supµ[Fn(µ − σ log σ) − Fn(µ)] ≥
2n−1(log σ)2 does not infinitely exist. So supµ[Fn(µ−σ log σ)−Fn(µ)] ≤ 2n−1(log σ)2,
i.e. we have proven the second part of Lemma 5.3.1.
The following Lemma strengthens the conclusions in Lemma 5.3.1, as the bounds
can be violated by a zero-probability event for each σ and the union of zero-
probability events may have non-zero probability as there are uncountable σ in
the range. Here, we list Lemma 5.3.2 without proof. A proof is given in Chen et al.
(2007).
Lemma 5.3.2 (Chen et al. (2007)) Except for a zero-probability event not de-
pending on σ, and under the same normal mixture assumptions, we have, for all
large enough n,
1. For each given σ, which satisfies 8
nT
< σ < exp(−2). We have
sup
µ
[Fn(µ− σ log σ)− Fn(µ)] ≤ 4δn(σ); (5.27)





[Fn(µ− σ log σ)− Fn(µ)] ≤ 2(log n)2/n. (5.28)
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5.3.2 Penalized Likelihood and Penalty Functions
The penalized likelihood-based method is used to counter the unboundedness of
ln(Ψ) while keeping the parameter space ⊖ unaltered. An important consideration
is what kind of penalty function pn(Ψ) is eligible. Ridolfi & Idier (1999, 2000) pro-
posed a class of penalty functions based on a Bayesian conjugate prior distribution,
but the asymptotic properties of the corresponding PMLE were not discussed. Un-
der some conditions on pn(Ψ), Ciuperca, Ridolfi & Idier (2003) attempted a proof
of strong consistency of the PMLE of Ψ under the normal mixture model. Chen
et al. (2007) noted that the proof contains a few loose steps which are difficult
to tighten. Chen et al. (2007) employed a very different tactic in establishing the
strong consistency of the PMLE for a class of penalty functions. In addition, they
had shown that PMLE is asymptotically efficient.
In the thesis, we employ techniques of Chen et al. (2007) and expand their
approach to the proof of the asymptotic consistency of PMLE for the CMDA1
model.






k=1 p̃n(σjk)+p̃n(σj)], where σjk’s are the class specific variances
and σj’s are the global variances;
C2. p̃n(σ)→ −∞ as σ → 0;
C3. supσ>0 max{0, p̃n(σ)} = o(n), and p̃n(σ) = o(n) at any fixed σ > 0.
Penalized Maximum Likelihood Estimate 134
C4. p̃n(σ) ≤ 4(log n)2 log σ, when σ ≤ 8/(nT ) as n is large enough.
In C1, penalty function pn(Ψ) is expressed as a sum of univariate penalty func-
tions, a form that is convenient for numerical computation by the EM algorithm.
Although each p̃n(·) in pn(Ψ) could use a different penalty, for notational conve-
nience we assume all penalties are of a single form p̃n(σ). To counter the effect
of an unbounded density function of the CMDA1 model as σ → 0, we must have
pn(Ψ) → −∞ as σj → 0 or σjk → 0 for each j = 1, . . . , P and k = 1, . . . , K. C3
rules out functions that substantially elevate or depress the penalized likelihood at
any parameter value. At the same time, C3 allows the penalty to be very severe
in a shrinking neighborhood of σ = 0. C4 determines the growth rate of penalty
functions, insuring that the penalized log-likelihood can not be infinite for any given
sample size. These four conditions are flexible and functions satisfying these condi-
tions can be easily found and constructed. Some examples will be given in Section
5.4.
5.3.3 Asymptotic Consistency of the PMLE for Two-Dimensional
Multivariate Mixture Models with Diagonal Covari-
ance Matrices
We first prove the asymptotic consistency of the PMLE for two-dimensional multi-
variate normal mixtures, with diagonal covariance matrices and two mixture com-
ponents. Since each class density of the two-dimensional CMDA1 model is a con-
strained case of multivariate normal mixtures, the theorem directly is applicable to
the two-dimensional CMDA1 model.
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which is based on some conditions: π 6= 0, 1 and (µ1, µ2, σ1, σ2) 6= (ν1, ν2, δ1, δ2).























and the penalty function
pn(Ψ) = p̃n(σ1) + p̃n(σ2) + p̃n(δ1) + p̃n(δ2), (5.31)
where Ψ = {π, µ1, µ2, ν1, ν2, σ1, σ2, δ1, δ2}. We penalize only variances. Here, the
penalty function is a little different from that in Section 5.3.2 as there are no global
parameters (σj ’s) in this unconstrained model. C2, C3 and C4 still hold for this






We also define the penalized log-likelihood function as
P ln(Ψ) = ln(Ψ) + pn(Ψ). (5.32)
We partition the parameter space into three regions. Figure 5.1 illustrates the
partition of the parameter space in the variance component.
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Figure 5.1: Partition of the parameter space Γ.
First, we define some constants that will be used later in the proof. Let K0 =
E0 log f(X;Ψ), where E0(·) means expectation with respect to the true density
f(X;Ψ0), i.e. K0 =
∫
log f(X;Ψ0)f(X;Ψ0)dx. It is seen that |K0| <∞. Also we
redefine the constant T in Section 5.3.1 as T = max{supx f(x;Ψ0), 8}, i.e. f(x;Ψ0)
now is a mixture of multivariate normal distributions. Let ǫ0 be a small positive
constant such that
• 0 < ǫ0 < exp(−2),
• 16Tǫ0(log ǫ0)2 ≤ 1,
• − log ǫ0 − (log ǫ0)2/2 ≤ 2K0 − 4,
It is easy to see that as ǫ0 goes to 0, the inequalities are satisfied. Hence, the exis-
tence of ǫ0 is assured. For some small τ0, we define three regions for the parameter
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space in Figure 5.1
Γa = {Ψ : σ1σ2 < δ1δ2 < ǫ0},
Γb = {Ψ : σ1σ2 ≤ τ0, δ1δ2 ≥ ǫ0},
Γc = Γ− (Γa ∪ Γb).
The exact size of τ0 will be specified in the proof of Theorem 4. The three
regions represent three situations. In Γa, the mixing distributions have at least one
of the scale parameters along each dimension (X1 and X2) close to zero. In this
case, the observations near any small location parameters contribute significantly
to the log likelihood ln(Ψ), but will be countered by the penalty. The log likelihood
contributions of the other observations can not exceed the likelihood at the true
mixing distribution. Hence, the PMLE of Ψ has diminishing probability to be in
Γa. In the second situation, at least one of the two mixing component distribu-
tions has one element of the scale parameter vector along X1 dimension close to
0. When the mixing distribution has some of the scale parameters close to zero,
the likelihood has two major sources: the observations near location parameters
with corresponding small scale parameters, and the remaining observations. The
first source is countered by the penalty. We will show that the likelihood from
the second source is not large enough to exceed the likelihood at the true mixing
distribution. Hence, the PMLE of Ψ also has diminishing probability to be in Γb.
Once the possibility of the first two regions is eliminated, the consistency for the
PMLE of Ψ in the third scenario Γc is established via the application of Kiefer &
Wolfowitz (1956)’s consistency proof.
Theorems 3 and 4 will prove that asymptotically the PMLE cannot fall in the
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Figure 5.2: Defined regions A and B. The centre of the region A is (µ1, µ2), and
the centre of the region B is (ν1, ν2).
first two regions. Theorem 5 shows that the PMLE must fall in the final region,
Γc, and is thus consistent.
Theorem 3 (Γa): Under the assumptions that the data are a random sample from




P ln(Ψ)− P ln(Ψ0)→ −∞.








)2 ≤ log2(δmin)}. Figure 5.2 illustrates the
regions of (xi1, xi2) for i ∈ A and i ∈ B in a two-dimensional space.
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So ln(Ψ) = ln(Ψ; A) + ln(Ψ; A
cB) + ln(Ψ; A
cBc). We investigate the asymptotic
order of these three terms. Let n(A) be the number of observations in set A. From
the fact that the mixture density is no larger than 1
σ1σ2
, we have
ln(Ψ; A) ≤ −n(A) log(σ1σ2), (5.33)
and
ln(Ψ; A
cB) ≤ −n(AcB) log(δ1δ2) ≤ −n(B) log(δ1δ2). (5.34)
Let A∗1 = {i : (xi1−µ1σ1 )
2 ≤ log2(σmin)} and A∗2 = {i : (xi2−µ2σ2 )
2 ≤ log2(σmin)} re-
spectively. It is clear that A ⊂ A∗1 and A ⊂ A∗2. Hence, n(A) ≤ min{n(A∗1), n(A∗2)}.





−4(log n)2 if 0 < σ1 < 8nT






−4(log n)2 if 0 < σ2 < 8nT
−8 + 8Tnσ2 log σ2 if 8nT < σ2 < ǫ0.
The above two bounds imply





−4(log n)2 when 0 < σmin < 8nT
−8 + 8Tnσmin log σmin when 8nT < σmin < ǫ0.






−4(log n)2 log(σ1σ2) if 0 < σmin < 8nT
(−8 + 8Tnσmin log σmin) log(σ1σ2) if 8nT < σmin < ǫ0.
From the two above inequalities and the conditions on the penalty functions, we
obtain that
ln(Ψ; A) + p̃n(σ1) + p̃n(σ2) < 0, (5.36)
when 0 < σmin <
8
nT
. Also, when 8
nT
< σmin < ǫ0, based on the choice of ǫ0, almost
surely, we arrive at the following bound:
ln(Ψ; A) + p̃n(σ1) + p̃n(σ2) ≤ (−8 + 8Tnσmin log σmin) log(σ1σ2)
≤ 8Tnǫ0(log ǫ0)2 + 9 log n. (5.37)
Similarly, we have
ln(Ψ; A
cB) + p̃n(δ1) + p̃n(δ2) ≤ 8Tnǫ0(log ǫ0)2 + 9 log n. (5.38)
For the observations that fall outside of both A and B, their likelihood contribu-





























which is negative. At the same time, we also have
n(A) + n(B) ≤ 2(log n)2/n + 2(log n)2/n = 4(log n)2/n < n
2
,
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for large n. This shows that n(A) + n(B) ≤ n
2
, which means there are always less
than half of the observations falling near location parameters (µ1, µ2) and (ν1, ν2).




{− log ǫ0 − (log ǫ0)2/2}. (5.40)
Then, combining the three bounds (5.37), (5.38) and (5.40), and recalling the choice
of ǫ0, we conclude that when Ψ ∈ Γa,
P ln(Ψ)
= ln(Ψ) + pn(Ψ)
= [ln(Ψ; A) + p̃n(σ1) + p̃n(σ2)] + [ln(Ψ; A
cB) + p̃n(δ1) + p̃n(δ2)] + [ln(Ψ; A
cBc)]




≤ n(K0 − 1) + 18 log n, a.s.. (5.41)
At the same time, by the strong law of large numbers




P ln(Ψ)− P ln(Ψ0) ≤ −n + 18 log n→ −∞ (5.43)
almost surely as n→∞.
Theorem 3 tells us that the PMLE can not be in Γa.
Now we move to the second scenario, which requires results for the second region
Γb. Unlike Γa, we have an unbounded Γb. Our first step is to compactify it. Define
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a distance on Γb by
d(Ψ,Ψ
′























arctan |δl − δ
′
l |. (5.44)
Under this distance, Γb is a totally bounded finite dimensional set, so it can be






















on Γb, with a1 = I(µ1 6= ±∞, σ1 6= 0; µ2 6= ±∞, σ2 6= 0) and a2 = I(ν1 6= ±∞; ν2 6=
±∞). The function g(·) is well defined over the entire space with some continuity.
The changes in the normal densities of g(·) ensure that the integral of g(·) is no
larger than 1 in order to use Jensen’s inequality in the following proof.
Let K(Ψ) = E0 log g(X;Ψ), which has the following property.
Lemma 5.3.3 For any {Ψn, n = 1, 2, . . .} ⊆ Γb, such that Ψn → Ψ, we have
limn→∞K(Ψn) ≤ K(Ψ). (5.46)
Proof: For any ρ > 0, define
g(x;Ψ, ρ) = sup{g(x;Ψ′); d(Ψ,Ψ′) < ρ,Ψ′ ∈ Γb}.
Note that limρ→0 g(x;Ψ, ρ) = g(x;Ψ), and sup{g(x;Ψ);Ψ ∈ Γb} ≤ 1ǫ0 .
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By the dominated convergence theorem,
lim
ρ→0
E0 log g(x;Ψ, ρ) = E0 log g(x;Ψ) = K(Ψ).
Let ρn = d(Ψ,Ψn), we have K(Ψn) ≤ E0 log g(x;Ψ, ρn), therefore,
limn→∞K(Ψn) ≤ limn→∞E0 log g(x;Ψ, ρn) = E0 log g(x;Ψ) = K(Ψ).
Theorem 4 (Γb): Under the assumptions that the data are a random sample from




P ln(Ψ)− P ln(Ψ0)→ −∞.
Proof: Lemma 5.3.3 tells us that there is Ψ∗ ∈ Γb such that K∗ = K(Ψ∗) =




} = K0 − K∗. The
dependence of δ(τ0) on τ0 is due to the dependence of Ψ
∗ on boundary τ0. δ(τ0) is
a decreasing function of τ0.





















By Jensen’s inequality, we have δ(τ0) > 0. We can find τ0 such that
1. τ0 < ǫ0,
2. 8Tτ0(log τ0)
2 < 2δ(ǫ0)/5 < 2δ(τ0)/5.
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We now proceed to show that the PMLE can not be in Γb. For any Ψ ∈ Γb
lim
ρ→0
E0 log g(x;Ψ, ρ) = E0 log g(x;Ψ) ≤ K∗.
Hence for each Ψ ∈ Γb, there exists a ρ(Ψ) > 0, such that








Let B(Ψ; ρ(Ψ)) = {Ψ′ ∈ Γb : d(Ψ,Ψ
′
) < ρ(Ψ)}, then B(Ψ; ρ(Ψ)) forms an open
cover of Γb. From the compactness of Γb, there are a finite number of Ψk, ρk, with


































The likelihood contribution of observations in A is no larger than − log(σ1σ2) +
log g(x;Ψ). For other observations, their likelihood contributions are less than















≤ exp{−(x1 − µ1)
2
4σ21
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+ 9 log n− pn(Ψ0)→ −∞ as n→∞. (5.49)
We now claim the strong consistency of the PMLE.
Theorem 5 Under the assumptions defined before, for any mixing distribution
Ψn = Ψn(X1, . . . ,Xn), satisfying
P ln(Ψn)− P ln(Ψ0) > c > −∞, (5.50)
we have that Ψn → Ψ0 almost surely as n→∞.
Proof: By Theorem 3 and Theorem 4, with probability one, Ψn ∈ Γc as n →
∞. Confining the mixing distribution Ψ in Γc is equivalent to placing a positive
constant lower bound for the variance parameters. Thus, the consistency is covered
by the result in Kiefer & Wolfowitz (1956). Note that their proof can be modified
to accommodate a penalty of size o(n) due to the conditions of their proof.
Let Ψ̂n be the PMLE that maximizes P ln(Ψ). By definition, P ln(Ψ̂n) −
P ln(Ψ0) > 0 and therefore Ψ̂n → Ψ0 almost surely. Hence we have proved that
PMLE Ψ̂n is strongly consistent in the Γc space.
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5.3.4 Asymptotic Consistency of PMLE for the CMDA1
Model in Two Dimensions
Now we can apply the above theorems to the two-dimensional CMDA1 model with
two classes. We put penalties on both class-specific and global variances. The log-













































and the penalty function as
pn(ΨCMDA) = p̃n(σ11) + p̃n(σ12) + p̃n(σ21) + p̃n(σ22) + p̃n(σ1) + p̃n(σ2). (5.51)
In order to prove the asymptotic consistency of the PMLE, we divide the log-
likelihood function into two parts, each of which represents one sample group (class
1 or class 2).
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and
Ψ1 = {µ11, µ12, σ11, σ12, µ1, µ2, σ1, σ2},
Ψ2 = {µ21, µ22, σ21, σ22, µ1, µ2, σ1, σ2}.
We define
P ln1(Ψ1) = ln1(Ψ1) + pn1(Ψ1), (5.53)
P ln2(Ψ2) = ln2(Ψ2) + pn2(Ψ2). (5.54)
Here, pn1(Ψ1) and pn2(Ψ2) are the penalty functions for the parameters in class
1 and class 2, respectively. Recall that the penalized MLE is the parameter value
(multi-dimensional) that maximizes the penalized log-likelihood function. From the
proof in Section 5.3.3, it is seen that the maximum point of both P ln1 and P ln2
are in the small neighborhood of the true parameter value. In fact, outside of any
small neighborhood, the suprema of two penalized log-likelihoods are smaller than
the penalized log-likelihoods at the true parameter value by an order of n. Thus,
the maximum of the sum of these two penalized log-likelihood must be inside any
small neighborhood of the true parameter value as n→∞. That is, the penalized
maximum likelihood of the CMDA1 model is asymptotically consistent.
5.4 A Simulation Study Using Two Penalty Func-
tions
We suggest two kinds of penalty functions, each of which comes from different
perspectives. One theme in these penalty functions is that they are related to the
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inverse gamma distribution, which is the conjugate prior for the complete data
likelihood. Penalization by an inverse gamma distribution induces no structural
changes in the EM algorithm and explicitness of the estimates is maintained.
The penalized log likelihood increases after each iteration (Green 1990). Fur-
thermore, penalization does not increase the computational burden as Green (1990)
pointed out that the penalized EM algorithm converges as least as quickly as the
standard one.
Section 5.4.1 discusses a non-Bayesian penalty function, while Section 5.4.2
focuses on a penalty function from Bayesian framework. The EM derivations for two
penalty functions will be presented before carrying out simulations. The simulations
are similar to those in Section 4.7.1.
5.4.1 A Non-Bayesian Perspective
The first penalty function is motivated by Chen et al. (2007). Some modifications
have been made in order to account the structure of the CMDA1 model. From the
experiments in Chapter 4, we found that the global variances do not converge to
degenerate solutions. Therefore, we only penalize local variances.






















where nk is the number of observations in class k; Sjk is the sample variance along
xj for the observations in the k
th class between the first and third sample quartiles
and Djk is an arbitrary positive constant. Here we need to emphasize that the
Penalized Maximum Likelihood Estimate 149
tuning parameter Djk is not a regularized parameter, but a constant that adjusts
the penalty functions. Since the within cluster variances are likely to be smaller
than the marginal sample variance of xj in class k, a trimmed variance Sjk is used.
This will also reduce sensitivity to outliers.
A desirable property of MLEs is their invariance: The MLE of a parameter can
be used to calculate the MLE of a one-to-one function of the parameter. PMLE’s do
not necessarily possess this functional invariance property. In order to incorporate
this nice feature, in the PMLE, Sjk’s are introduced in the penalty function. In the
following sections, the choice of Djk will be discussed in detail. It is not hard to
verify that this penalty function satisfies the four requirements (C1-C4) in Section
5.3.2.
EM Derivation of PMLE



































The closed form expressions for parameter estimates in the EM framework at




ijk = p̂(the i




























































































































We note that the only change is the inclusion of extra terms in the numerator
and denominator of σ̂2jk
(a+1) in (5.60).
Choice of Djk
We consider using the same constant for each Djk for convenience, i.e. D11 = . . . =
DPK = D. D is an adjusting parameter and corresponds to the prior mode. First, a
range of D values, (0.001, 0.005, 0.01, 0.05, 0.1, 2, 3, 4, 5, 6) is used to test sensitivity
to the tuning parameter D using the model from combination 7 in Table 4.4. The
true parameter values for this model are given in Table 5.1. The five factors of
the 7th combination are: dimensionality is 2, the class variances are the same, the
sample size is large, the data are unbalanced, and the means are well separated.
The ratio of active and inactive compounds in this example is 1 : 9. The true value
of σ11 is close to 0, i.e. σ11 = 0.1639. Figure 5.3 shows us that large D values push
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True Parameters
µjk µ11 = −4.4508 µ12 = −5.7968 µ21 = 2.4323 µ22 = 1.5012
µj µ1 = 4.4315 µ2 = 4.5122
σjk σ11 = 0.1639 σ12 = 0.1639 σ21 = 1.1383 σ22 = 1.1383
σj σ1 = 0.1709 σ2 = 1.0361
Table 5.1: The model corresponding to combination 7 in Table 4.4.
the PMLE far away from the true σ11, while the first several small D values have
little effect on the PMLE.
One further experiment is conducted to verify if D is scale-invariant. We multi-
ply x1 by 1000, and repeat the above experiment. The similar boxplot of PMLEs of
σ11 = 0.1639 obtained from the new experiment indicates that D does not depend
on data and gives consistent estimates in the range (0.001, 1). It is not surprising
that D is independent from data as Sjk and σ
2
jk in the penalty function (5.57) can-
cel the scaling effect. In the remainder of this chapter, D = 0.1 is chosen for the
penalty function P1.
Degenerate Solutions
As in Section 4.7.2, we can study whether the EM and modified EM algorithms
(Multi-step EM) return degenerate PMLE’s. Models from the first 16 combinations
in Table 4.4 are used here to verify that the PMLE can avoid degenerate solutions.
Combining the results from the previous chapter, Table 5.2 clearly shows that the
PMLE totally avoids degenerate solutions no matter which algorithm is used. For
combinations 17-32, the same conclusion can be made, i.e. PMLE does not converge
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Figure 5.3: Boxplot of PMLEs of σ11 = 0.1639 vs. D (0.001, 0.005, 0.01, 0.05, 0.1,
2, 3, 4, 5, 6).
to degenerate solutions for high-dimensional cases.
Parameter Estimates
We report MSE’s for estimates of class-specific variances (σ2ij , i = 1, 2, j = 1, 2) for
the first 16 simulation models in Table 4.4. Two algorithms are used to calculate
PMLE’s and MLE’s: the Multi-step EM algorithm and the EM algorithm. So there
are four different scenarios: PMLE/Multi-step EM, PMLE/EM, MLE/Multi-step
EM and MLE/EM.
MSE’s of both PMLE and MLE calculated via the conventional EM algorithm
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1 2 3 4 5 6 7 8
PMLE (Multi-step EM) 0 0 0 0 0 0 0 0
MLE (Multi-step EM) 0 0 0 20 0 0 0 1
PMLE (EM) 0 0 0 0 0 0 0 0
MLE (EM) 103 200 174 200 3 200 44 199
9 10 11 12 13 14 15 16
PMLE (Multi-step EM) 0 0 0 0 0 0 0 0
MLE (Multi-step EM) 0 1 0 14 0 0 0 1
PMLE (EM) 0 0 0 0 0 0 0 0
MLE (EM) 24 145 77 157 0 68 1 83
Table 5.2: Degenerate solutions from PMLE and MLE calculated by Multi-step
EM and the EM algorithm.
are plotted as pairs in Figure 5.4. Most points fall in the bottom half of the plot, i.e.,
the MSE’s of the MLE are larger than those of the PMLE. Therefore, PMLE gives
more accurate parameter estimates. MSE’s of both PMLE and MLE calculated via
Multi-step EM are plotted in Figure 5.5. Most MSE’s are on the 45−degree line,
which indicates that Multi-step EM has significantly improved estimation accuracy
for the MLE. The number of points above the diagonal are roughly equal to those
below, so there is no large difference in the parameter accuracy between the PMLE
and the MLE when Multi-step EM is used to do the parameter estimation.
The above discussion also tells us that even though Multi-step EM for MLE
can converge to degenerate solutions some time, this algorithm has improved the
accuracy of parameter estimation compared to the EM algorithm. Unlike the PMLE
that requires careful choice of tuning parameters, the Multi-step EM algorithm is
easily implemented.
Penalized Maximum Likelihood Estimate 154






















PMLE vs MLE via EM
Figure 5.4: MSE of variances (σ2ij , i = 1, 2, j = 1, 2) from PMLE and MLE calcu-
lated by EM for the first 16 simulation models. Degenerate solutions are included.
There are in total 64 points in the plot. Each point represents a pair of MSE from
PMLE and MLE of one variance parameter estimated via the EM algorithm.
In the following examples, the PMLE is estimated by the EM algorithm.
Consistency Testing
Since the number of components in the CMDA1 models is fixed, it is meaningful to
investigate the bias and variance properties of individual parts of the PMLE. In this
section, we generate data from two simulation models in Table 4.4 to illustrate the
consistency property of the PMLE. Example 1 is a two-dimensional example sim-
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Figure 5.5: MSE of variances from PMLE and MLE calculated by Multi-step EM
for the first 16 simulation models. Degenerate solutions are included.
ulated from the 12th combination in Table 4.4, and Example 2 is a 10-dimensional
example simulated from the 28th combination. Both examples are among the more
difficult classification problems in their own dimensionality. For Example 1, two
sample sizes, n = 70 and n = 280 are considered. Similar to Example 1, two differ-
ent sample sizes are also used to examine the consistency for Example 2: n = 390
and n = 1, 560.

























2) = (0.5, 0.5, 1.432, 0.501,−1.705,−1.463,−0.900, 1.533,
0.164, 0.379, 0.171, 1.036, 0.775, 0.102). The mean biases and standard deviations
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Size µ11 µ12 µ21 µ22 µ1 µ2
70 -0.091∗ 0.027 0.001 -0.008 0.008 -0.008∗
(0.254) (0.235) (0.030) (0.189) (0.146) (0.027)
280 0.001 -0.007 0.000 0.003 0.001 -0.001
(0.079) (0.107) (0.016) (0.100) (0.070) (0.009)
σ11 σ12 σ21 σ22 σ1 σ2
70 0.078∗ -0.180∗ -0.004∗ -0.033∗ -0.023∗ 0.020∗
(0.260) (0.138) (0.021) (0.140) (0.092) (0.060)
280 -0.009 -0.023∗ -0.002∗ -0.002 0.000 0.000
(0.068) (0.077) (0.011) (0.067) (0.053) (0.016)
π11 π12 π21 π22
70 0.049∗ -0.049∗ 0.001∗ -0.001∗
(0.112) (0.112) (0.006) (0.006)
280 0.003 -0.003 0.001∗ -0.001∗
(0.033) (0.033) (0.002) (0.002)
Table 5.3: Biases and standard deviations (in brackets) of parameter estimates for
Example 1 using the PMLE with P1(Ψ). The biases that are significantly different
from zero at a 5% significance level are indicated by ∗.
(in brackets) of parameter estimates are calculated from the 200 data sets simu-
lated from the model and presented in Table 5.3.
The biases in Table 5.3 are computed in terms of µ11−µ011. When the sample size
increases, all the biases and standard deviations decrease indicating the consistency
of the PMLE for the CMDA1 model.
We are also interested in knowing which of these biases are significantly different
from zero, i.e. whether the average estimates of the parameters are significantly
different from the true parameters. With a large sample size (200 replicates) we
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simply use a t-test. Table 5.3 indicates that all biases for the estimates of σ’s and
π’s are significantly different from the true σ’s and π’s when the sample size is small.
As the sample size increases, fewer parameter estimates are significantly different
from the true parameters.
Example 2: A 10-dimensional CMDA1 model (the 28th combination in Table 4.4).
The parameters of true mixing distribution are listed in Table 5.4. All the π’s are
equal to 0.1 in this case. Due to the burden of computation, only 100 data sets are
generated from the model. We list the biases and standard deviations of the PMLE
of σjk’s and σj ’s in Table 5.5. As in the previous example, the bias and variance
of the parameter estimates decrease as the sample size increases. A similar pattern
may be seen in the location parameters and mixing proportions (not shown here).
Although we did not prove the asymptotic consistency for higher-dimensional
CMDA1 models, this example suggests that the higher-dimensional CMDA1 models
can be asymptotically consistent.
We also conduct the same hypothesis tests as in Example 1 to see if the biases
of the parameter estimates are significantly different from the true parameters. As
the sample increases, there are less biases that are significantly different from the
truth (28 when the sample size is 390 vs. 23 when the sample size is 1560).
5.4.2 A Bayesian Perspective
In this section, we focus on using proper inverse gamma priors for the local vari-
ances as the penalty function. The prior for σ2jk is an inverse gamma distribution,
i.e. σ2jk ∼ IG(ν/2, νλ/2), and this is equivalent to specifying νλ/σ2jk ∼ χ2ν with
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µ11 µ12 µ13 µ14 µ15
0.405 -2.702 0.370 2.797 0.060
µ16 µ17 µ18 µ19 µ110
1.206 -2.878 1.701 0.506 -1.096
µ21 µ22 µ23 µ24 µ25
2.977 0.186 -2.341 0.799 1.788
µ26 µ27 µ28 µ29 µ210
1.278 1.217 0.377 -1.447 0.042
µ1 µ2 µ3 µ4 µ5
1.361 1.092 -2.777 0.109 0.787
µ6 µ7 µ8 µ9 µ10
1.112 1.276 0.293 2.334 -0.098
σ11 σ12 σ13 σ14 σ15
0.164 0.379 0.057 0.345 0.258
σ16 σ17 σ18 σ19 σ110
0.034 0.369 0.292 0.108 0.128
σ21 σ22 σ23 σ24 σ25
0.525 1.133 0.476 1.299 1.146
σ26 σ27 σ28 σ29 σ210
0.109 0.739 0.953 0.127 0.876
σ1 σ2 σ3 σ4 σ5
0.244 1.207 0.434 0.108 0.822
σ6 σ7 σ8 σ9 σ10
1.015 0.678 1.236 0.136 0.183
Table 5.4: The true mixing distribution (µ’s and σ’s ) for Example 2.
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Sample σ11 σ12 σ13 σ14 σ15
390 -0.027 -0.007 -0.018∗ -0.105∗ -0.090∗
(0.169) (0.358) (0.021) (0.121) (0.213)
1560 0.088∗ -0.005 -0.001 -0.016∗ -0.037
(0.197) (0.260) (0.010) (0.071) (0.256)
σ16 σ17 σ18 σ19 σ110
390 0.089∗ -0.069∗ -0.035∗ -0.056∗ -0.106∗
(0.208) (0.202) (0.306) (0.051) (0.048)
1560 0.051∗ 0.005 0.021∗ -0.029∗ -0.111∗
(0.199) (0.187) (0.050) (0.044) (0.036)
σ21 σ22 σ23 σ24 σ25
390 -0.030∗ -0.655∗ -0.251∗ -0.422∗ -0.616∗
(0.077) (0.417) (0.194) (0.609) (0.454)
1560 -0.014∗ -0.258∗ -0.153∗ -0.333∗ -0.300∗
(0.041) (0.473) (0.193) (0.546) (0.395)
σ26 σ27 σ28 σ29 σ210
390 0.197∗ -0.499∗ -0.499∗ -0.005∗ -0.179∗
(0.388) (0.264) (0.405) (0.017) (0.408)
1560 0.044∗ -0.428∗ -0.355∗ 0.000 -0.033
(0.194) (0.280) (0.437) (0.007) (0.281)
σ1 σ2 σ3 σ4 σ5
390 0.008∗ 0.015∗ 0.008∗ 0.222∗ 0.028∗
(0.013) (0.058) (0.026) (0.302) (0.054)
1560 0.005∗ 0.011∗ 0.004∗ 0.158∗ 0.0176∗
(0.009) (0.043) (0.013) (0.256) (0.039)
σ6 σ7 σ8 σ9 σ10
390 -0.034∗ -0.009∗ -0.023∗ 0.034∗ 0.064∗
(0.056) (0.030) (0.058) (0.041) (0.067)
1560 -0.012∗ 0.001 -0.022∗ 0.025∗ 0.049∗
(0.029) (0.016) (0.031) (0.042) (0.047)
Table 5.5: Biases and standard deviations of the standard deviation estimates for
Example 2 using the PMLE with P1(Ψ). The biases that are significantly different
from zero at a 5% significance level are indicated by ∗.




when ν > 2 and V ar(σ2jk) =
2ν2λ2
(ν−2)2(ν−4)
for ν > 4. This prior distribu-
tion is identical to the likelihood for σ2jk arising from a data set with ν observations













































Then the close form expressions for parameter estimates in the EM framework
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The fact that E(σ2jk) =
λjkνjk
νjk−2
for νjk > 2 suggests that λjk should be chosen
near the expected class specific variance σ2jk. In the absence of expert knowledge,
some fraction of the sample variance along jth direction of the kth class could be









This represents the prior belief that standard deviation of the class specific variance
will be roughly 1/5 of the sample standard deviation along jth direction. Chipman
(2006) used a similar idea when specifying a prior on the residual variance σ2 in
linear regression.
We choose νjk = 5, for j = 1, . . . , P and k = 1, . . . , K. This represents our
belief that the prior distribution does not have a long tail and is centered around
λjk. for νjk = 5, the prior (0.1, 0.5, 0.9) quantiles for σ
2
jk are 0.54, 1.15 and 3.10
times λjk respectively.
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For the penalty P2, the same experiments as in the penalty P1 are conducted
to verify that the PMLE from P2 does not converge to any degenerate solution.
The comparisons between PMLE/Multi-step, MLE/Multi-step, PMLE/EM and
MLE/EM gives the same conclusion as in P1, i.e. there is no difference between
PMLE/Multi-step and PMLE/EM; the PMLE gives more accurate parameter es-
timates than the MLE.
For the consistency testing of the PMLE under the penalty function P2, the
same Example 1 (combination 12) is used in the simulation. The simulation results
(the biases and standard deviations of the parameter estimates of the PMLE) are
presented in Table 5.6. The fact that all biases and standard deviations have
gotten smaller with the larger samples suggests that MSE drops with increasing
sample size and that PMLE’s should be asymptotically consistent. Therefore, the
PMLE of the CMDA1 model under the penalty P2 is also asymptotically consistent.
We also considered Example 2 for this penalty function. Results were similar to
Section 5.4.1, and are not reproduced here.
5.5 Drug Discovery Data
We use the EM algorithm to estimate the PMLE of the CMDA1 model for the real
drug data: NCI Antiviral AIDS Data using the first penalty P1. The same 4 splits of
the random samples as in Chapter 4 are used here. Performance is assessed by the
AHR on the test set. The two different results (MLE/Multi-step and PMLE/EM)
are presented in Table 5.7. Over the four replications, a paired t-test concludes
that there is no significant difference between MLE/Multi-step and PMLE/EM at
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Size µ11 µ12 µ21 µ22 µ1 µ2
70 -0.139∗ 0.058∗ 0.784∗ 2.935∗ -0.722∗ -2.619∗
(0.485) (0.328) (0.192) (0.445) (0.133) (0.421)
280 -0.024∗ 0.000 0.004∗ 0.034∗ 0.046∗ -0.194∗
(0.121) (0.115) (0.018) (0.139) (0.069) (0.081)
σ11 σ12 σ21 σ22 σ1 σ2
70 -0.068∗ -0.319∗ -0.072∗ -1.002∗ -0.416∗ 1.197∗
(0.020) (0.017) (0.018) (0.015) (0.181) (0.199)
280 -0.006∗ -0.314∗ -0.057∗ -0.947∗ -0.007 0.702∗
(0.003) (0.013) (0.001) (0.001) (0.050) (0.201)
π11 π12 π21 π22
70 0.0183∗ -0.018∗ 0.013∗ -0.013∗
(0.067) (0.067) (0.019) (0.019)
280 0.013∗ -0.013∗ 0.002∗ -0.002∗
(0.041) (0.041) (0.003) (0.003)
Table 5.6: Biases and standard deviations (in brackets) of parameter estimates for
Example 1 using the PMLE with P2(Ψ). The biases that are significantly different
from zero at a 5% significance level are indicated by ∗.







Table 5.7: NCI data: AHR (%) for MLE/Multi-step and PMLE/EM.
Class π1k π2k π3k π4k π5k π6k
Active 0.13 0.25 0.08 0.20 0. 16 0.18
Inactive 0.04 0.07 0.25 0.27 0. 19 0.18
Table 5.8: The penalized estimates of mixing proportions estimated from Split2.
a 5% significance level.
Some interpretations of the model parameters may be possible. For example,
large mixing proportions may be interpreted as evidence of the importance of the
associated predictors. Consider the mixing proportions estimated from Split 2
shown in Table 5.8. It is interesting to see that both the active and inactive classes
identify BCUT4 and BCUT6 as important variables, which are the same as the
finding from Wang (2005).
Since both Multi-step EM and EM algorithms only give point estimates, it is
difficult to do inference on the estimates. In future research, we can use some
techniques to calculate standard errors for the estimates, which will be discussed
in Chapter 6.
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5.6 PMLE for the Second Order Model (CMDA2)
In this section, we consider a penalized maximum likelihood estimator for the
CMDA2 model. As in Section 5.3.3, the penalized likelihood function is written as
P ln(Ψ) = ln(Ψ) + pn(Ψ). (5.72)
Before discussing the form of penalty term pn, we review the form of the CMDA2
model, originally described in Section 4.10.
5.6.1 The CMDA2 Model
This model explores the two-dimensional subsets of descriptors. For P descriptors,
there are P (P − 1)/2 components in each class, as each component is specified by
a pair of descriptors. The second order model can be written as







N(xl; µl, σl), (5.73)
where Ψk = {µjk,Σjk}P (P−1)/2j=1 is the local parameter for class k and ΨG =
{µl, σl}Pl=1 is the global parameter. Here j indexes a pair of descriptors, i.e. j =
1, . . . , P (P − 1)/2 corresponds to pairs {(1, 2), (1, 3), . . . , (P − 1, P )}.
5.6.2 The Penalty Function for the CMDA2 Model
According to the multivariate analogues of Chen & Tan (2007), the penalty func-
tion for the CMDA2 model should have the following properties in order that the
parameter estimates are asymptotically consistent:






C2. At any fixed Ψ such that |Σjk| > 0 for all j = 1, . . . , P and k = 1, . . . , K, we
have pn(Ψ) = o(n), and supΨ max{0, pn(Ψ)} = o(n). pn(Ψ) is differentiable
with respect to Ψ and as n → ∞, p′n(Ψ) = o(
√
n) at any fixed Ψ such that
|Σjk| > 0 for all j = 1, . . . , P and k = 1, . . . , K.
C3. For large enough n, p̃n(Σ) ≤ 4(log n)2 log |Σ|, when |Σ| is smaller than cn−2
for some c > 0.
An additive function is used as the penalty function, so C1 simplifies the numer-
ical computation. C2 limits the effect of penalty. C3 means that the penalty will
counteract both σj = 0 and Σ that are degenerate such as a Σ corresponding to
variables with correlations of ±1. This is a new kind of degeneracy not encountered
in the CMDA1 model.
5.6.3 PMLE for the NCI Antiviral AIDS Data
In the section, the penalized CMDA2 model is applied on the NCI Antiviral Aids
data to obtain the penalized maximum likelihood estimates. We use the Wishart
















{tr(Sjk−1Σjk) + log |Σjk|}, (5.74)
where Sjk is the mode of the prior distribution. Dk ∈ ℜ+ is a tuning parameter,
whose increasing values implies a stronger concentration of the density near Sjk.
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l 6=j N(xl; µl, σl)
∑p(p−1)/2
j∗=1 π̂j∗kMV N(xj∗ ; µj∗k,Σj∗k)
∏

























































In the application, we assume Dk = D, k = 1, . . . , K. A sequence of D, i.e.
D = (1.5, 2, 3, 4, 5, 6, 7, 8), is used to identify the best one, which gives highest AHR
for the testing set. We find that D in the range of (1.5, 8) returns similar values of
AHR, so D = 1.5 is chosen in the computation. We choose Sjk to be the sample
covariance matrix of the two class-specific descriptors of the jth component. That
is, training data with y = k are used for the sample covariance of xj1 and xj2, when
j = (j1, j2).
As before, the CMDA2 model is applied on the NCI antiviral AIDS Data with





), where x̄ is the sample mean and s is the sample standard deviation.
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Figure 5.6: Normal transformation of the subspace (x4, x6) of the NCI data with
300 active and 300 inactive compounds: Left, before transformation; Right, after
transformation. Red and blue represent two classes.
Figure 5.6 shows the data before and after the transformation. It is clear that after
transformation, outliers are pushed toward the centre of the data, so the effect of
outliers can be reduced through transformation.
We apply both the CMDA2 model and the MclustDA model with 15 compo-
nents to the NCI Antiviral AIDS Data with the 4 same training-testing splits as in
previous sections. The training and test sets each have n = 14, 906 compounds, of
which 304 are active compounds. We conduct four experiments (4 splits), which will
be referred to as “Split 1”, . . ., “Split 4” in the text below. Performance is assessed
by the AHR on the test set. The AHR’s returned from both approaches for the 4
splits are listed in Table 5.9. A paired t-test is conducted and the p−value = 0.521
indicates that there is no statistically significant difference between the penalized
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CMDA2 and MclustDA.
Compared to the AHR’s returned by the CMDA1 model, the CMDA2 model has
higher AHR’s for the four different splits. Therefore, the CMDA2 model does have
a better performance than the CMDA1 model. A paired t-test is also performed
and the p−value = 0.036 confirms the previous conclusion that the CMDA2 model
outperforms the CMDA1 model.
Furthermore, the CMDA2 model may give insight into the data. For example,
mixture components with large weights represent large proportions of the data.
Since each component is associated with a two-dimensional subspace, a large weight
π implies that data are concentrated in this subspace, and that the subspace may
be useful for discriminating active compounds. Table 5.10 lists the estimates of
the mixing proportions for the second split of the NCI data. The active class
identifies the descriptor pairs (1, 4), (2, 4) and (3, 4) as important mechanisms, and
the inactive class identifies (1, 2), (2, 4) and (3, 4) as important mechanisms.
It is interesting to note the prevalent role that x4 plays in the active components,
as this was identified previously by Wang (2005) as the most important predictor.
5.7 Discussion
In this chapter, the PMLE for the two-dimensional CMDA1 model has been proven
to be asymptotically consistent, which is confirmed by the simulations. Although
the consistency for higher-dimensional CMDA1 models has not been proved, the
simulation results suggest that high-dimensional CMDA1 models may also be asymp-
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Split CMDA1 CMDA2 MclustDA(15)
1 11.87 17.76 22.14
2 13.09 14.64 16.27
3 11.34 16.91 13.49
4 10.22 19.20 21.39
Average 11.63 17.13 18.32
Table 5.9: AHR (%) for the CMDA1 model, the PMLE of the CMDA2 model and
the MclustDA model with 15 components.
Subspaces (x1, x2) (x1, x3) (x1, x4) (x1, x5) (x1, x6)
Active 0.078 0.043 0.211 0.028 0.063
(x2, x3) (x2, x4) (x2, x5) (x2, x6) (x3, x4)
0.095 0.180 0.025 0.005 0.196
(x3, x5) (x3, x6) (x4, x5) (x4, x6) (x5, x6)
0.034 0.006 0.020 0.009 0.007
Subspaces (x1, x2) (x1, x3) (x1, x4) (x1, x5) (x1, x6)
Inactive 0.177 0.029 0.093 0.043 0.068
(x2, x3) (x2, x4) (x2, x5) (x2, x6) (x3, x4)
0.077 0.151 0.049 0.038 0.160
(x3, x5) (x3, x6) (x4, x5) (x4, x6) (x5, x6)
0.052 0.012 0.016 0.011 0.024
Table 5.10: The estimates of mixing proportions corresponding to each subspace
from Split2.
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totically consistent.
For the NCI data, the CMDA2 model has better performance than the CMDA1
model by generating higher AHR. This indicates that the CMDA2 model can rep-
resent the data better than the CMDA1 model. However, we also find that the
CMDA2 model is very sensitive to the initial values, i.e. different initial values give
different parameter estimates although the AHR’s obtained are very close. This
may occur because the CMDA2 model can only catch one mechanism in each sub-
space (i.e. a single normal mixture component). This may not be sufficient to catch
the whole structure of the NCI data.
Choosing reasonable values of the tuning parameters for the penalty functions
becomes an important question in the PMLE approach. The variances or covariance
matrices of the subspaces of the data and the assessment of sensitivity of results
to different penalization parameter values can provide guidance to choose the right
values for the tuning parameters.
The fact that the performance of the MclustDA model with 15 components is
much better than that of the MclustDA model with 6 components indicates that
adding extra components may improve the performance of the CMDA1 model.
Furthermore, the CMDA2 model performed better than the CMDA1 model. This
indicates that both the number of components and two-dimensional component
structure of the CMDA2 model are helpful in ranking active compounds.
Chapter 6
Future Research
This chapter is divided into three parts. Section 6.1 describes the future research
of Cluster Structure-Activity Relationship (CSARA) analysis. The future research
for the CMDA model and the PMLE are presented in Section 6.2 and Section 6.3
respectively.
6.1 CSARA
In the analysis of the CSARA method, the large number of clusters (e.g. 3, 000,
5, 000, 10, 000, etc) were used in the study. Exactly one compound was randomly
selected from each cluster to act as the training data regardless of cluster size. The
response from a single compound will be quite variable. A more stable approach
might be to reduce the number of clusters and select more compounds per cluster.
Also the approach will allow the number of compounds sampled to vary according
to cluster size. The modification will increase the chance of identifying more active
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compounds as a large sample from the cluster should provide more information on
cluster features. Therefore, the problem how to choose multiple compounds from
each cluster arises.
It is also interesting to note that with multiple samples per cluster, some rank-
ing of clusters may be possible. The current approach of assaying one compound
per cluster yields only a 0/1 activity label, which makes it impossible to predict
the probability of active compounds in each cluster and difficult to rank clusters
according to the predicted activity probabilities. However, sampling multiple com-
pounds can make it possible to estimate a proportion of actives and use this for
cluster ranking.
6.2 CMDA
The challenges presented by QSAR modeling have been listed in Section 1.3: (1)
unbalanced response or rare target problem, (2) multiple mechanisms, (3) subspace-
governed activity, (4) nonlinear relationship among descriptors and (5) measure-
ment errors. In Chapter 4, the primary focus was the CMDA1 model, which handles
the first three challenges. For the fourth challenge of nonlinear relationship, the
CMDA2 model may provide better representation of drug discovery data as it can
represent bivariate dependencies within mixture component. A more careful and
systematic simulation design is needed to explore the characteristics of the CMDA2
model. A challenge encountered with applying the current implementation of the
CMDA2 model to drug discovery data is the larger impact of outliers not due to
measurement errors. Modifications of the method capable of dealing with outliers
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will be an important extension. The large number of mixture components and
bivariate dependence structure of the CMDA2 model makes computations very
intensive. Efficient algorithms using parallel computing need to be developed.
We also want to test the order of CMDA models, i.e. the number of components
in each class. For example, the CMDA1 model can have more than P components.
Identifying the number of components in mixture models is an important topic,
which is related to model selection techniques. In the mixture context, such model
selection can be implemented by seeking to set some mixing proportions to be zero
or to constrain other parameters across mixtures. One possible approach is the
use of Lasso-type penalties (Tibshirani 1996 and Fan & Li 2001). In the future
research, we would like to include this feature into our current algorithm and do
model selection automatically.
We notice that selecting or identifying important variables for a drug discovery
data set is meaningful. This problem can be viewed as a kind of model selection.
The techniques described in the previous paragraph may be relevant, since each
component of both the CMDA1 and CMDA2 models is associated with one or two
particular variables.
In the thesis, the CMDA model has been applied only to two-class data. The
CMDA model may require slight changes in order to be applied to the data with
multiple classes. Further, in order to incorporate various descriptors (e.g. cate-
gorical, ordinal, etc.), the component densities can be discrete, and other types of
density functions.
Usually, drug discovery data can have hundreds descriptors. In such high di-
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mensions, the CMDA model may not work as well due to the large number of
parameters and the complexity of the model structure. So some sort of dimen-
sion reduction strategy may need to be used under this context. Some algorithms,
such as recursive partitioning and random forest, can preliminarily determine the
optimal subset of descriptors to reach the aim of dimension reduction.
6.3 Penalized Maximum Likelihood Estimation
Chapter 5 proves the asymptotic consistency of the PMLE for two-dimensional mul-
tivariate normal mixtures with diagonal covariance matrices. In future research, we
want to prove the asymptotic consistency of the PMLE for higher dimensional mul-
tivariate normal mixtures without independence constrains. The tentative approach
may be calculating the largest eigenvalue for each component given the class label
k, then counting the number of observations dropping in a small neighbourhood
of the local parameter along the dimension of the largest eigenvalue. The proof
should be similar to the approach taken in Chapter 5.
For both the PMLE and the MLE, the EM algorithm only gives point estimates
without any uncertainty measurements, so it is not currently possible to make
inference for the estimates from two approaches. Later, we will modify the multi-
step EM algorithm by adding one more step, i.e. calculating the covariance matrix
for the MLE or the PMLE. Bootstrap techniques can be also used to get empirical
uncertainty for parameter estimates. Finally, we also can try a Markov Chain Monte
Carlo (MCMC) approach to quantify parameter uncertainty (Bensmail, Celeux,
Raftery & Robert (1997) and Richardson & Green (1997)). Since PMLE’s can be
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viewed as the estimates using prior distributions, a Bayesian approach to inference
would be a natural extension.
Appendix A: Related Theories
Theorem 6 (Dominated Convergence Theorem) Lebesgue’s dominated con-
vergence theorem states that if a sequence {fn : n = 1, 2, . . .} of real-valued mea-
surable functions on a measurable space S converges almost everywhere, and is










i.e. |fn(x)| ≤ g(x) for every n and almost every x (i.e. the measure of the set of




Theorem 7 (Kolmogorov’s Strong Law of Large Numbers) Let {Xi} be I.I.D.






Xi →wp1 c (6.2)
holds if and only if E{Xi} is finite and equals c.
Theorem 8 (Bernstein’s Inequality) Let Y1, . . . , Yn be independent random vari-

















for all n = 1, 2, . . ..
Theorem 9 (Borel-Cantelli Lemma) (i) For arbitrary events Bn, if
∑
n P (Bn) <
∞, then P (Bn infinitely often) = 0.
(ii) For independent events Bn, if
∑
n P (Bn) = ∞, then P (Bn infinitely often) =
1.
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